Williams Syndrome
Williams syndrome is a rare genetic neurodevelopmental disorder caused by a microdeletion on chromosome 7q11.23, presenting in infancy and childhood with supravalvular aortic stenosis, distinctive elfin facies, intellectual disability, hypercalcemia, and a characteristically overly friendly personality.
Williams Syndrome (Williams-Beuren Syndrome)
Williams syndrome (WS), also known as Williams-Beuren syndrome, is a contiguous gene deletion syndrome caused by a hemizygous microdeletion on chromosome 7q11.23, encompassing approximately 26–28 genes including the critical elastin (ELN) gene [1][2]. The deletion spans approximately 1.5–1.8 Mb and results in a multisystem disorder characterised by a distinctive "elfin" facies, cardiovascular disease (especially supravalvular aortic stenosis), intellectual disability, a unique neurocognitive profile, hypercalcaemia, and a characteristic behavioural phenotype of overfriendliness [1][2][3].
Etymology / Name breakdown:
- "Williams" — after Dr J.C.P. Williams (New Zealand cardiologist) who first described the syndrome in 1961
- "Beuren" — after Dr Alois Beuren (German cardiologist) who independently described it in 1962
- The condition is a microdeletion syndrome — "micro" = small, "deletion" = loss of genetic material; the deletion is too small to see on standard karyotype and requires FISH or chromosomal microarray for detection
High Yield Concept — Contiguous Gene Deletion
Williams syndrome is a classic example of a contiguous gene deletion syndrome — multiple adjacent genes are deleted together, producing a constellation of features. Each deleted gene contributes to different aspects of the phenotype. The elastin gene (ELN) deletion is responsible for the cardiovascular and connective tissue features, while other deleted genes (e.g., LIMK1, GTF2I, GTF2IRD1, CLIP2) contribute to the neurocognitive and behavioural profile [1][2].
| Parameter | Detail |
|---|---|
| Incidence | ~1 in 7,500–20,000 live births [1][2] |
| Sex ratio | M = F (no sex predilection) [1] |
| Inheritance | Majority de novo (~95%); autosomal dominant if inherited (rare) [1][2] |
| Recurrence risk | If parent affected: 50%; if de novo: < 5% (consider gonadal mosaicism) |
| Ethnic distribution | All ethnicities equally affected |
- In Hong Kong, the incidence is consistent with worldwide figures. Given HK's birth rate (~35,000–40,000 live births/year), approximately 2–5 new cases per year would be expected.
- Because the majority are de novo deletions, there is usually no family history — the deletion arises as a new event during meiosis, specifically due to non-allelic homologous recombination (NAHR) between flanking low-copy repeats on chromosome 7.
The 7q11.23 region contains ~26–28 genes. Understanding which gene produces which feature is essential:
| Gene | Normal Function | Consequence of Deletion |
|---|---|---|
| ELN (Elastin) | Encodes elastin — the major structural protein of arterial walls, skin, lungs, and connective tissue; provides elastic recoil | Supravalvular aortic stenosis, peripheral pulmonary stenosis, systemic arterial stenosis, renal artery stenosis, connective tissue laxity |
| LIMK1 | LIM kinase 1 — involved in actin cytoskeleton remodelling in neurons; spatial processing | Visuospatial construction deficits |
| GTF2I / GTF2IRD1 | General transcription factors — regulate gene expression in neural crest-derived tissues | Craniofacial dysmorphism ("elfin" facies), intellectual disability, hypersociability |
| CLIP2 (CYLN2) | Cytoplasmic linker protein — role in intracellular transport in neurons | Contributes to cognitive deficits |
| RFC2 | DNA replication factor | Uncertain clinical significance |
| BAZ1B (WBSCR9) | Chromatin remodelling; regulates neural crest cell migration | May contribute to hypercalcaemia and craniofacial features |
| STX1A | Syntaxin 1A — involved in insulin secretion | May contribute to glucose metabolism abnormalities |
3.1 Elastin — Why It Matters So Much
Elastin is the key structural protein in large and medium arteries. It is synthesised as tropoelastin by vascular smooth muscle cells, secreted into the extracellular space, and cross-linked into mature elastic fibres. In the aorta, elastin constitutes ~50% of the dry weight of the vessel wall.
Why does ELN haploinsufficiency cause supravalvular aortic stenosis?
- With only one functional copy of ELN, there is ~50% reduction in elastin production
- The arterial wall compensates by smooth muscle cell hyperplasia and increased collagen deposition
- This makes the vessel wall thicker, stiffer, and narrowed — particularly at high-stress points like the sinotubular junction (just above the aortic valve), producing supravalvular aortic stenosis (SVAS)
- The same process can affect any artery → generalised elastin arteriopathy
4. Aetiology and Pathophysiology
- Caused by 7q11.23 deletion (involving the elastin gene) [1]
- The deletion occurs due to non-allelic homologous recombination (NAHR) between low-copy repeat (LCR) sequences flanking the Williams-Beuren syndrome critical region (WBSCR)
- These LCR blocks are highly homologous (~98% identical), making them prone to misalignment during meiosis → unequal crossing over → deletion on one chromosome (and duplication on the other — 7q11.23 duplication syndrome is a separate entity)
- Majority de novo (~95%) [1]
- Autosomal dominant if transmitted from an affected parent (50% risk to offspring)
- Rarely, atypical deletions (smaller or larger than typical) produce partial phenotypes
4.2 Pathophysiology by System
Secondary to elastin arteriopathy involving any artery, occurs in 75% of patients [2].
| Lesion | Mechanism | Clinical Significance |
|---|---|---|
| Supravalvular aortic stenosis (SVAS) | Elastin deficiency → smooth muscle hyperplasia at sinotubular junction → narrowing above aortic valve | Most common cardiovascular finding [2][3]; can be progressive; may cause LVH, heart failure |
| Peripheral pulmonary stenosis (PPS) | Same mechanism in pulmonary arterial branches | Common in infancy; often improves with age as pulmonary arteries grow [2] |
| Renal artery stenosis | Elastin arteriopathy of renal arteries | Can lead to secondary hypertension [2] |
| Coronary artery ostial stenosis | Thickening of aortic wall at coronary ostia → narrowed coronary origins | Risk of myocardial ischaemia and sudden death (especially during anaesthesia) |
| Systemic arterial stenosis | Any medium/large artery can be affected (coeliac, mesenteric, cerebral) | Generalised arterial hypertension |
Critical Point — Sudden Cardiac Death Risk
Williams syndrome patients have an increased risk of sudden cardiac death, particularly during anaesthesia or sedation. This is due to:
- Coronary artery ostial stenosis → myocardial ischaemia
- Severe biventricular outflow tract obstruction (combined SVAS + PPS)
- Arrhythmias secondary to myocardial hypertrophy
Always ensure cardiology review and echocardiography before any procedure requiring sedation/anaesthesia [2][3].
Characteristic elfin-like face [1] — the facial features result from abnormal neural crest cell development and connective tissue structure (due to loss of GTF2IRD1, GTF2I, and ELN):
| Feature | Pathophysiological Basis |
|---|---|
| Broad forehead [2] | Altered craniofacial bone growth |
| Periorbital fullness of subcutaneous tissues [1][2] | Connective tissue abnormality |
| Short palpebral fissures [1] | Orbital development anomaly |
| Flat nasal bridge with anteverted nares [1][2] | Midface hypoplasia |
| Long philtrum [2] | Neural crest-derived tissue abnormality |
| Full/thick lips, wide mouth (usually held open) [1][2] | Connective tissue laxity and muscle tone |
| Small, widely spaced teeth (microdontia) [1][2] | Dental dysplasia; enamel hypoplasia, malocclusion, excessive interdental spacing [2] |
| Small chin (micrognathia) [1] | Mandibular hypoplasia |
| Prominent ears / prominent earlobes [1][2] | Cartilage/connective tissue |
| Blue eyes with stellate/starry iris pattern (~50%) [1] | Abnormal iris stromal development — a beautiful and distinctive sign |
| Round face with full cheeks [1] | Subcutaneous tissue and buccal fat pad |
| Flared eyebrows / medial eyebrow flare [1] |
The facial features become more recognisable with age — in infancy, the face may appear round with periorbital fullness; by school age and adolescence, the "elfin" features are more pronounced, with coarsening of features.
- Developmental delay and intellectual disability (~75%): usually mild-moderate [1][2]
- Mean IQ approximately 55–60 (range 40–90)
- Unique neurocognitive profile: relatively preserved language and auditory rote memory, with extreme deficits in visuospatial construction [2]
- Why? The LIMK1 gene deletion specifically impairs dorsal stream visual processing ("where" pathway), affecting spatial reasoning, block design, and drawing tasks
- Language is relatively spared because the neural substrates for language (left temporal-parietal regions) are less dependent on the deleted genes
- Hoarseness or low-pitched voice [2] — due to connective tissue changes in the larynx
Abnormal behaviour: over-friendly manner (happy/cocktail party personality) [1]
| Feature | Mechanism |
|---|---|
| Overfriendliness / excessive empathy [1][2] | Loss of GTF2I → altered amygdala reactivity to social stimuli; reduced social inhibition |
| Anxiety / specific phobias [2] | Paradoxically, despite social disinhibition, there is increased generalised anxiety and noise phobia |
| Sleeping difficulties [2] | Altered melatonin metabolism; anxiety |
| Attention problems (ADHD) [2] | Executive function deficits |
| Hyperacusis [1] | Increased auditory sensitivity — may be related to altered auditory processing or middle ear anatomy; associated with specific phobias to loud noises |
The 'Cocktail Party' Personality
Children with Williams syndrome are characteristically extremely sociable and gregarious — they approach strangers without fear, make intense eye contact, and show remarkable verbal fluency in social settings (hence "cocktail party personality"). However, this apparent social strength masks significant social vulnerability — they have difficulty reading social cues, forming deep friendships, and are at risk of exploitation. This overfriendliness is a red flag for the condition [1][2].
| Feature | Mechanism |
|---|---|
| Transient neonatal hypercalcaemia (~15%) [1]; hypercalciuria (~30%) [2] | Possibly related to increased intestinal calcium absorption and/or altered vitamin D metabolism; BAZ1B deletion may play a role. Usually returns to normal by 12 months [1]. Associated with vomiting, feeding difficulties, constipation and prolonged colic [2] |
| Hypothyroidism (~10%) [1][2] | Mechanism not fully understood; may be subclinical; requires monitoring |
| Early puberty [1] | Altered hypothalamic-pituitary-gonadal axis |
- Kyphoscoliosis [1] — due to connective tissue laxity from elastin deficiency
- Joint laxity in childhood → joint contractures in adulthood
- Pes planus (flat feet)
- Hypotonia in infancy
5. Classification
Williams syndrome does not have a formal subtype classification, but can be conceptualised along these axes:
| Type | Deletion Size | Phenotype |
|---|---|---|
| Classic/Typical deletion (~95%) | ~1.55 Mb | Full Williams syndrome phenotype |
| Larger atypical deletion | > 1.8 Mb | More severe intellectual disability; may have additional features |
| Smaller atypical deletion | < 1.5 Mb (partial deletion) | Partial phenotype — isolated SVAS if only ELN deleted |
| Pattern | Frequency |
|---|---|
| De novo | ~95% [1] |
| Inherited (autosomal dominant) | ~5% (from affected parent) |
| Gonadal mosaicism | Rare but important for genetic counselling |
- Isolated familial supravalvular aortic stenosis: Point mutations or small deletions of ELN only (without the full contiguous gene deletion) → isolated SVAS without the cognitive/behavioural phenotype
- 7q11.23 duplication syndrome: The reciprocal duplication produces a different phenotype — speech delay, autism-spectrum features, and social anxiety (essentially the "opposite" of the Williams behavioural phenotype)
6. Clinical Features
| Symptom | Age of Presentation | Pathophysiological Basis |
|---|---|---|
| Feeding difficulties / poor weight gain | Neonatal / infancy | Oral motor dysfunction, hypotonia, GOR, hypercalcaemia-related vomiting |
| Vomiting, constipation, prolonged colic | Infancy | Hypercalcaemia [2] → decreased GI motility, increased renal concentration |
| Irritability / excessive crying | Infancy | Hypercalcaemia; hyperacusis causing distress from everyday sounds |
| Failure to thrive | Infancy – early childhood | Caloric insufficiency from feeding difficulties; possible endocrine factors |
| Developmental delay — late walking, late talking | Infancy – toddler | Mild-moderate intellectual disability [1]; hypotonia |
| Difficulty with drawing, puzzles, spatial tasks | Preschool onwards | Extreme visuospatial construction deficit [2] — LIMK1 deletion |
| "My child talks to everyone" | Toddler – school age | Overfriendliness / cocktail party personality [1][2] |
| Anxiety, phobias (especially noise phobia) | School age | Altered amygdala processing; hyperacusis [2] |
| Sleeping difficulties | Any age | Anxiety; melatonin dysregulation [2] |
| Attention problems | School age | ADHD [2] |
| Hearing concerns | Any age | Chronic otitis media; sensorineural hearing loss [1][2] |
| Shortness of breath / exercise intolerance | Depends on severity of cardiac disease | SVAS → LV pressure overload → LVH → reduced cardiac output |
| Chest pain (rare, ominous) | Any age | Coronary ostial stenosis → myocardial ischaemia |
| Polyuria / polydipsia | If hypercalcaemia significant | Hypercalcaemia → nephrogenic diabetes insipidus (Ca²⁺ interferes with aquaporin-2 in collecting duct) |
6.2 Signs (What the Clinician Finds)
| Sign | Detail | Basis |
|---|---|---|
| Short stature | Below 3rd-10th percentile for age | Growth delay; endocrine factors [1] |
| Elfin-like facies | See detailed table above | Neural crest / connective tissue [1][2] |
| Stellate iris pattern | Blue eyes with starry pattern (~50%) [1] | Iris stromal hypoplasia |
| Wide mouth usually held open | With thick/prominent lips [1][2] | Connective tissue laxity; low muscle tone |
| Small, widely spaced teeth | Microdontia, enamel hypoplasia [1][2] | Dental dysplasia |
| Hoarse or low-pitched voice | [2] | Laryngeal connective tissue changes |
| Joint hypermobility (childhood) | Beighton score may be elevated | Elastin deficiency → connective tissue laxity |
| Sign | Detail | Basis |
|---|---|---|
| Ejection systolic murmur at right upper sternal border radiating to carotids | Supravalvular AS | Narrowing at sinotubular junction; turbulent flow through stenosis |
| Ejection systolic murmur at left upper sternal border radiating to back and axillae | Peripheral pulmonary stenosis | Multiple branch stenoses in pulmonary arterial tree |
| Blood pressure discrepancy (R arm > L arm) | If coarctation-like stenosis or aortic arch involvement | Arterial narrowing |
| Hypertension | May be present | Renal artery stenosis → secondary hypertension; or generalised elastin arteriopathy [2] |
| Pulse: may be low-volume with slow upstroke | Severe SVAS | Fixed obstruction to LV outflow |
Supravalvular vs. Valvular Aortic Stenosis — Key Differences
In supravalvular AS (Williams syndrome), the narrowing is above the valve at the sinotubular junction. This has important consequences:
- The coronary arteries arise below the stenosis, so they are exposed to high LV systolic pressure → coronary artery dilation, accelerated atherosclerosis, and ostial stenosis
- There is no ejection click (unlike valvular AS where the thickened valve leaflets produce a click)
- The murmur is loudest at the right upper sternal border and radiates to the neck/carotids
- BP may be higher in the right arm (Coanda effect — the jet of blood through the stenosis preferentially enters the innominate/right subclavian artery)
| Sign | Basis |
|---|---|
| Hypotonia (infancy) | Central hypotonia; connective tissue laxity |
| Hyperreflexia (older children/adults) | Upper motor neuron signs may develop |
| Poor fine motor coordination | Visuospatial deficits + motor planning difficulties |
| Relatively fluent speech (may appear more capable verbally than functionally) | Preserved language relative to visuospatial skills — the "cocktail party" verbal fluency |
| Sign | Basis |
|---|---|
| Inguinal/umbilical hernia | Connective tissue laxity |
| Rectal prolapse (rare) | Connective tissue laxity |
A useful mnemonic for remembering the features:
| Letter | Feature |
|---|---|
| W | Wide mouth, friendly personality |
| I | Increased calcium (hypercalcaemia) |
| L | Long philtrum |
| L | Learning difficulties (mild-moderate ID) |
| I | Iris — stellate pattern |
| A | Aortic stenosis (supravalvular) |
| M | Mental retardation (prefer "intellectual disability") |
| S | Small stature / Small teeth |
Understanding when features present helps with early recognition:
| Age | Key Features |
|---|---|
| Neonate | Feeding difficulties, prolonged jaundice, transient hypercalcaemia, heart murmur (may not be detected yet), hypotonia |
| Infant (1–12 months) | Failure to thrive, irritability/colic (hypercalcaemia), peripheral pulmonary stenosis murmur, characteristic facies becoming apparent |
| Toddler (1–3 years) | Developmental delay (motor > language), elfin facies more recognisable, SVAS murmur now prominent, overfriendly behaviour emerging |
| Preschool (3–5 years) | Visuospatial deficits apparent on testing, cocktail party personality, ADHD/anxiety, hyperacusis |
| School age | Learning difficulties (especially maths, spatial reasoning), behavioural issues, hypertension may develop |
| Adolescence/Adult | Short stature, joint contractures replacing hypermobility, progressive SVAS, hypertension, diabetes mellitus, hearing loss, anxiety disorders |
| Parameter | Normal Range (Age-Dependent) | Relevance in WS |
|---|---|---|
| Serum calcium (total) | Neonate: 2.0–2.6 mmol/L; Child: 2.2–2.7 mmol/L | Hypercalcaemia (> 2.7 mmol/L) in ~15% |
| Serum ionised calcium | 1.1–1.3 mmol/L | More accurate than total Ca |
| TSH | 0.7–6.0 mIU/L (varies by age) | Hypothyroidism — elevated TSH |
| Free T4 | 10–26 pmol/L (varies by age) | Low in hypothyroidism |
| Blood pressure | Age-, sex-, height-specific percentiles (< 90th) | Hypertension if ≥ 95th percentile on 3 occasions |
10. Growth and Development in Williams Syndrome
- Prenatal growth: Usually normal
- Postnatal growth: Failure to thrive in infancy; short stature throughout childhood
- Specific Williams syndrome growth charts (Morris et al.) should be used — plotting on standard growth charts will show consistently low centiles
- Mean adult height: approximately 10th percentile of general population (~152 cm females, ~164 cm males)
- Gross motor: Delayed — mean walking age ~21 months (vs. normal 12–15 months); hypotonia contributes
- Fine motor: Significantly delayed; visuospatial construction deficits are prominent
- Language: Relatively preserved compared to other domains — may give a misleading impression of higher overall ability ("cocktail party speech"); vocabulary may be surprisingly good but comprehension is limited
- Social: Overfriendliness and indiscriminate social approach — a diagnostic clue but also a safeguarding concern
- Breaking the diagnosis: Parents often notice "something different" about the face or developmental progress. The diagnosis should be communicated sensitively, emphasising the child's strengths (sociability, verbal skills) while being honest about challenges.
- Genetic counselling: Most cases are de novo — reassure parents about low recurrence risk (~< 5% due to potential gonadal mosaicism). If a parent is affected, recurrence risk is 50%.
- Consent/Assent: For genetic testing and cardiac investigations, consent is obtained from parents/guardians. As the child matures, age-appropriate assent should be sought, recognising the intellectual disability.
- Multidisciplinary team: Cardiologist, geneticist, developmental paediatrician, speech therapist, occupational therapist, dietitian, psychologist, audiologist, ophthalmologist, nephrologist, endocrinologist.
Williams syndrome is listed alongside 22q11.2 deletion syndrome, Loeys-Dietz syndrome, Marfan syndrome, Long QT syndrome, and Noonan syndrome as a "rare disease among common disease(s)" [5] — meaning these are rare genetic conditions that may initially present with common paediatric problems (e.g., heart murmur, developmental delay, short stature, feeding difficulties) before the unifying diagnosis is recognised.
GC Lecture High Yield — Rare Diseases Among Common Diseases
Williams syndrome should be considered in any child presenting with:
- Supravalvular aortic stenosis (pathognomonic association)
- Elfin facies + intellectual disability + overfriendliness
- Hypercalcaemia in infancy
- Peripheral pulmonary stenosis in a neonate/infant
The GC lecture groups it with other genetic syndromes with cardiac manifestations — know the cardiac associations for each syndrome [5]:
- Down syndrome → AVSD, VSD
- Turner syndrome → Coarctation, bicuspid aortic valve
- Williams syndrome → Supravalvular AS, peripheral PS [3]
- Noonan syndrome → Valvular PS, HCM
- DiGeorge (22q11.2 deletion) → Conotruncal defects (interrupted aortic arch, truncus arteriosus, ToF)
High Yield Summary
Williams Syndrome — Key Facts for Exams:
- 7q11.23 microdeletion including the elastin (ELN) gene — majority de novo [1][2]
- Elfin facies: broad forehead, periorbital fullness, flat nasal bridge, anteverted nares, long philtrum, full lips, wide mouth, small widely spaced teeth, prominent ears, stellate iris [1][2]
- Supravalvular aortic stenosis — most common and most characteristic cardiac lesion [2][3]
- Peripheral pulmonary stenosis — common in infancy, often improves [2]
- Elastin arteriopathy → any artery can be affected → renal artery stenosis → hypertension [2][3]
- Coronary ostial stenosis → risk of sudden cardiac death (especially under anaesthesia)
- Intellectual disability (75%, mild-moderate) with characteristic profile: preserved language, extreme visuospatial deficit [1][2]
- Overfriendly / "cocktail party" personality — pathognomonic behavioural phenotype [1][2]
- Hypercalcaemia (~15%) — transient neonatal, causes feeding difficulties and colic; hypercalciuria (~30%) [1][2]
- Hypothyroidism (~10%) [1][2]; early puberty [1]
- Short stature / failure to thrive [1][2]
- Hyperacusis and sensorineural/conductive hearing loss [1][2]
- Diagnosis by FISH or chromosomal microarray (CMA) — not visible on standard karyotype
- Associations to remember: WILLIAMS = Wide mouth, Increased Ca²⁺, Long philtrum, Learning difficulties, Iris (stellate), Aortic stenosis (supravalvular), Mental retardation, Small stature/teeth
Active Recall - Williams Syndrome (Definition, Epidemiology, Aetiology, Pathophysiology, Clinical Features)
[1] Senior notes: Adrian Lui Pediatrics Notes.pdf (p. 514 — Williams Syndrome) [2] Senior notes: MBBS Final MB (Pediatrics) (Felix PY Lai).pdf (p. 878 — Williams Syndrome) [3] Senior notes: Ryan Ho Cardiology.pdf (p. 185 — Common syndromes associated with congenital heart diseases) [4] Lecture slides: CFB (PAE02) Child growth and development.pdf [5] Lecture slides: GC 151. The malformed child hereditary syndromes and anomalies.pdf (p. 36 — Rare diseases among common diseases)
Differential Diagnosis of Williams Syndrome
Williams syndrome rarely presents as a neat diagnostic label on first encounter. Instead, a child presents with one or more of its cardinal features — and each feature has its own differential diagnosis. The clinician's job is to recognise the pattern that unifies these features and distinguishes Williams from its mimics.
The key presenting problems that trigger a differential include:
- A dysmorphic child (elfin facies + intellectual disability)
- A heart murmur / congenital heart disease (especially supravalvular aortic stenosis)
- Hypercalcaemia in infancy
- Short stature / failure to thrive
- Developmental delay with a distinctive neurocognitive/behavioural profile
- Hypertension in a child
We will work through the differential from each of these "entry points," then bring them together.
1. Differential Diagnosis by Presenting Feature
This is the most common exam framing: you see a child with distinctive facies + developmental delay + congenital heart disease and must identify the syndrome. The GC lecture "The malformed child: hereditary syndromes and anomalies" [5] explicitly groups Williams syndrome with other "rare diseases among common disease(s)" — conditions that may initially present with common paediatric problems before a unifying syndromic diagnosis is recognised.
| Syndrome | Genetics | Key Dysmorphic Features | Characteristic Cardiac Defect | Distinguishing Feature from WS |
|---|---|---|---|---|
| Williams syndrome [1][2][3][6] | 7q11.23 deletion (elastin gene) | Elfin facies, stellate iris, full lips, wide mouth, periorbital fullness | Supravalvular AS, peripheral PS | — (this is the index condition) |
| Down syndrome [1][3] | Trisomy 21 | Upslanting palpebral fissures, epicanthic folds, flat nasal bridge, protruding tongue, brachycephaly, single palmar crease | AVSD, VSD, ASD, PDA, ToF | Hypotonia, Brushfield spots; no hypercalcaemia; global delay without the visuospatial/verbal dissociation |
| Noonan syndrome [1][3][6] | RASopathy (PTPN11, etc.) | Turner-like but normal karyotype, both sexes; ptosis, downslanting palpebral fissures, low-set ears, webbed neck, shield chest | Valvular PS (dysplastic valve), HCM | Right-sided cardiac lesions (vs. WS which is arterial stenosis); cryptorchidism in males; bleeding tendency |
| Turner syndrome [1][3] | 45,X | Short stature, webbed neck, low hairline, cubitus valgus, widely spaced nipples | Left-sided: Coarctation of aorta, bicuspid aortic valve | Females only; lymphoedema in neonates; streak gonads; no hypercalcaemia, no overfriendliness |
| DiGeorge syndrome (22q11.2 deletion) [1][3][5] | 22q11.2 deletion | Low-set posteriorly rotated ears, hypertelorism, cleft palate, thymic hypoplasia | Conotruncal defects: interrupted aortic arch, truncus arteriosus, ToF | Hypocalcaemia (opposite of WS which has hyper-Ca²⁺ — because DiGeorge involves parathyroid hypoplasia → ↓PTH); immune deficiency |
| Marfan syndrome [5][6] | FBN1 mutation | Tall stature, arachnodactyly, joint hypermobility, high-arched palate, ectopia lentis | MVP, AR, aortic root dilation | Tall stature (WS is short); lens dislocation upward; normal intelligence; connective tissue laxity but different mechanism (fibrillin-1 vs. elastin) |
| Fragile X syndrome [6] | FMR1 CGG repeat expansion (X-linked) | Long face, large ears, prominent mandible, macrocephaly | MVP (minor) | Macro-orchidism post-puberty; most common genetic cause of learning difficulties; autism features; no hypercalcaemia |
| Foetal alcohol spectrum disorder (FASD) | Prenatal alcohol exposure | Smooth philtrum, thin vermillion border, short palpebral fissures, midface hypoplasia | VSD, ASD, ToF | Maternal alcohol history; no hypercalcaemia; microcephaly; growth restriction prenatal + postnatal |
| Loeys-Dietz syndrome [5] | TGFBR1/TGFBR2 mutations | Hypertelorism, bifid uvula/cleft palate, arterial tortuosity | Aortic root aneurysm, arterial aneurysms | Aggressive arterial aneurysm formation (vs. arterial stenosis in WS); bifid uvula is pathognomonic |
| Costello syndrome | HRAS mutation (RASopathy) | Coarse facies, redundant skin, curly hair, deep palmar creases | PS, HCM | Papillomata; increased malignancy risk; coarse facies distinct from elfin |
Key distinguishing principle: Williams syndrome produces arterial stenosis (especially supravalvular aortic stenosis) — this is virtually pathognomonic. If you see supravalvular AS in a child, think Williams syndrome first. No other common syndrome produces this specific lesion.
Supravalvular aortic stenosis (SVAS) is the most common cardiovascular finding in Williams syndrome [2]. However, SVAS can also occur in:
| Cause | Mechanism | How to Differentiate |
|---|---|---|
| Williams syndrome | ELN haploinsufficiency → diffuse elastin arteriopathy | Elfin facies, ID, hypercalcaemia, overfriendliness — multisystem |
| Familial (isolated) SVAS | Point mutations or small intragenic deletions of ELN only | Autosomal dominant inheritance; SVAS without dysmorphism, without cognitive/behavioural features; family history of SVAS |
| Homozygous familial hypercholesterolaemia | Severe atherosclerosis affecting aortic root | Xanthomata; very high LDL; onset in older childhood/teens |
| Post-surgical (e.g., after arterial switch for TGA) | Scarring/fibrosis at surgical anastomosis site | History of cardiac surgery |
| Rubella embryopathy | Viral-induced arteritis during fetal development | Cataracts, deafness, PDA; maternal rubella history |
Transient neonatal hypercalcaemia (~15%) [1] is an important early clue to Williams syndrome. The DDx of neonatal/infantile hypercalcaemia includes:
| Cause | Mechanism | Distinguishing Features |
|---|---|---|
| Williams syndrome | Possibly ↑ intestinal Ca²⁺ absorption; altered vitamin D sensitivity; BAZ1B deletion | Elfin facies, SVAS, transient (resolves by ~12 months [1]) |
| Idiopathic infantile hypercalcaemia (IIH) | CYP24A1 mutations → impaired inactivation of 1,25(OH)₂D | No dysmorphism; persistent or recurrent; genetic testing distinguishes |
| Primary hyperparathyroidism | PTH-secreting adenoma or neonatal severe hyperparathyroidism (NSHPT from homozygous CaSR mutation) | Very high PTH; NSHPT presents neonatally with severe hypercalcaemia |
| Subcutaneous fat necrosis | Activated macrophages in necrotic fat produce 1,25(OH)₂D | History of birth trauma/hypothermia; firm subcutaneous nodules |
| Vitamin D intoxication | Excessive supplementation → ↑ Ca²⁺ absorption | Medication history; very high 25(OH)D levels |
| Phosphate depletion | e.g., in preterm infants on phosphate-poor feeds | Premature infant; low serum phosphate |
| Familial hypocalciuric hypercalcaemia (FHH) | Heterozygous loss-of-function CaSR mutation → ↑ renal Ca²⁺ reabsorption | Mild hypercalcaemia, low urinary Ca²⁺ excretion, benign; autosomal dominant |
| Malignancy | PTHrP secretion (rare in infants) | Tumour evident on imaging |
| Condition | Key Distinguishing Feature |
|---|---|
| Williams syndrome | Elfin facies, SVAS, hypercalcaemia, overfriendliness |
| Turner syndrome | Females only, webbed neck, coarctation, streak gonads |
| Noonan syndrome | Both sexes, valvular PS/HCM, cryptorchidism, bleeding tendency |
| Down syndrome | Characteristic facies, AVSD, hypotonia |
| Russell-Silver syndrome | Hemihypertrophy, triangular face, limb asymmetry, normal head size relative to body, clinodactyly — NO cardiac defect typically |
| Growth hormone deficiency | Proportionate short stature, no dysmorphism, delayed bone age |
| Constitutional delay | Normal variant, positive family history, delayed bone age, eventually reaches normal height |
The "cocktail party" personality is relatively specific to Williams syndrome, but overfriendly behaviour can also be seen in:
| Condition | How It Differs from WS |
|---|---|
| Angelman syndrome (15q11.2 deletion, maternal) | "Happy puppet" — frequent laughter, hand-flapping, ataxic gait, severe ID, seizures; no SVAS or hypercalcaemia |
| ADHD (isolated) | No dysmorphism, no cardiac disease, no hypercalcaemia |
| Autism spectrum disorder (paradox) | Children with WS are often excessively social (opposite of classic ASD); however, social cognition is impaired in both — just manifested differently |
| Foetal alcohol spectrum disorder | Smooth philtrum, thin upper lip; maternal alcohol history |
Renal artery stenosis → secondary hypertension [2] is an important complication of Williams syndrome. In a child with hypertension:
| Cause | Clue |
|---|---|
| Williams syndrome (renal artery stenosis / generalised elastin arteriopathy) [2][3] | Elfin facies, SVAS, known WS diagnosis |
| Renal parenchymal disease (GN, reflux nephropathy, CKD) | Abnormal urinalysis, ↑ creatinine, small/scarred kidneys on US |
| Coarctation of aorta | Diminished and delayed femoral pulses, reduced femoral BP [7]; upper-lower limb BP gradient |
| Phaeochromocytoma | Paroxysmal hypertension, headaches, sweating; skin stigmata of neurofibromatosis [7] |
| Conn syndrome / adrenal hyperplasia | Hypokalaemia |
| Cushing syndrome | Cushing facies, striae, central obesity [7] |
| Essential hypertension | Older child/adolescent, obese, family history; most common cause in adolescents |
| Fibromuscular dysplasia | Young female; renal bruit; "string of beads" on angiography |
The following mermaid diagram illustrates how a clinician moves from the presenting feature to the correct syndromic diagnosis:
A very useful clinical pearl in the paediatric syndrome DDx is the direction of calcium abnormality:
| Syndrome | Calcium | Why |
|---|---|---|
| Williams syndrome | Hypercalcaemia ↑ | Altered vitamin D metabolism / intestinal absorption (BAZ1B and related genes) |
| DiGeorge syndrome (22q11.2 deletion) | Hypocalcaemia ↓ | Parathyroid hypoplasia → ↓PTH → ↓Ca²⁺ |
| Down syndrome | Usually normal | No specific calcium disturbance |
| Noonan syndrome | Usually normal | No specific calcium disturbance |
| Turner syndrome | Usually normal | No specific calcium disturbance |
Exam Pearl — Hyper- vs. Hypocalcaemia in Syndromic DDx
If an OSCE or written paper gives you a dysmorphic child with a heart murmur and hypercalcaemia → think Williams syndrome (SVAS). If the same child has hypocalcaemia → think DiGeorge (22q11.2 deletion) (conotruncal defects). The calcium direction is a quick discriminator between two commonly tested syndromes [1][2][3].
| WS Feature | Other Conditions Sharing This Feature | Key Differentiator |
|---|---|---|
| Supravalvular AS | Familial isolated SVAS, rubella embryopathy, homozygous FH | Only WS has the full constellation of elfin facies + ID + behavioural phenotype |
| Peripheral pulmonary stenosis | Noonan syndrome, Alagille syndrome, congenital rubella | Alagille has bile duct paucity + butterfly vertebrae + posterior embryotoxon; Noonan has dysplastic valvular PS |
| Hypercalcaemia (infantile) | IIH (CYP24A1), subcutaneous fat necrosis, vitamin D excess, FHH, NSHPT | Only WS has the associated facies + cardiac lesion |
| Overfriendly behaviour | Angelman syndrome, ADHD | Angelman has severe ID, seizures, absent speech, ataxia; ADHD has no dysmorphism |
| Stellate iris | Relatively specific to WS | Very useful "spot diagnosis" sign |
| Elfin facies | Leprechaunism (Donohue syndrome — severe insulin resistance) | Leprechaunism has severe IUGR, lipoatrophy, hyperinsulinism |
| Short stature + ID | Many syndromes — non-specific | Must use the pattern of associated features to differentiate |
| Feature | Williams | Down | Noonan | Turner | DiGeorge |
|---|---|---|---|---|---|
| Genetics | 7q11.23 del | Trisomy 21 | RASopathy | 45,X | 22q11.2 del |
| Facies | Elfin | Flat, upslanting | Turner-like, ptosis | Webbed neck | Low-set ears, cleft |
| Cardiac | Supravalvular AS | AVSD | Valvular PS, HCM | Coarctation | Conotruncal |
| Calcium | ↑ Hyper | Normal | Normal | Normal | ↓ Hypo |
| Behaviour | Overfriendly | Generally amiable | Variable | Normal | Psychiatric risk |
| Immune | Normal | ↑ Leukaemia risk | Normal | Normal | T-cell deficiency |
| Sex | M = F | M = F | M = F | F only | M = F |
| Stature | Short | Short | Short | Short | Variable |
When facing a child with suspected Williams syndrome or any syndromic diagnosis:
- Pattern recognition — Do the facial features fit? (elfin facies = Williams; flat face + upslanting fissures = Down; webbed neck = Turner/Noonan)
- Cardiac lesion type — The single most discriminating feature in the syndrome-cardiac association table
- Calcium level — Hypercalcaemia (Williams) vs. hypocalcaemia (DiGeorge)
- Behavioural phenotype — Overfriendliness is highly suggestive of Williams
- Confirm genetically — FISH or chromosomal microarray for 7q11.23 deletion
High Yield Summary — Differential Diagnosis of Williams Syndrome
When to suspect Williams syndrome over mimics:
- Supravalvular AS is virtually pathognomonic — no other common syndrome produces it [2][3]
- Elfin facies + hypercalcaemia + overfriendliness = Williams until proven otherwise [1][2]
- Calcium direction distinguishes WS (↑Ca²⁺) from DiGeorge (↓Ca²⁺)
- Cardiac lesion type distinguishes all major syndromes: SVAS = Williams, AVSD = Down, valvular PS = Noonan, coarctation = Turner, conotruncal = DiGeorge [1][3][5][6]
- The GC lecture groups Williams with 22q11.2 deletion, Marfan, Noonan, Loeys-Dietz, and Long QT as "rare diseases among common diseases" [5] — know all their cardiac associations
- Familial isolated SVAS (ELN point mutations) is the closest genetic differential — same cardiac lesion but no dysmorphism, cognitive, or behavioural features
Active Recall - Differential Diagnosis of Williams Syndrome
References
[1] Senior notes: Adrian Lui Pediatrics Notes.pdf (p. 184, 514 — Williams Syndrome, Syndromic cardiac associations) [2] Senior notes: MBBS Final MB (Pediatrics) (Felix PY Lai).pdf (p. 878 — Williams Syndrome) [3] Senior notes: Ryan Ho Cardiology.pdf (p. 185 — Common syndromes associated with congenital heart diseases) [5] Lecture slides: GC 151. The malformed child hereditary syndromes and anomalies.pdf (p. 36 — Rare diseases among common diseases) [6] Senior notes: Maksim Paediatric Notes.pdf (p. 206 — Williams syndrome, Noonan syndrome, Marfan syndrome, Fragile X) [7] Senior notes: Block A - High blood pressure_ hypertension.pdf (p. 25 — Secondary hypertension physical exam features)
Diagnostic Criteria, Diagnostic Algorithm, and Investigations for Williams Syndrome
1. Diagnostic Criteria
Williams syndrome does not have a formal points-based diagnostic scoring system (unlike, say, the revised Jones criteria for rheumatic fever). Instead, diagnosis relies on:
- Clinical suspicion based on pattern recognition of cardinal features
- Confirmation by genetic testing demonstrating the 7q11.23 deletion [1][2]
The diagnosis is therefore a two-step process: clinical recognition → genetic confirmation.
A clinical diagnosis of Williams syndrome should be suspected when ≥ 2 of the following cardinal features are present in a child:
| Cardinal Feature | Frequency | Detail |
|---|---|---|
| Characteristic "elfin" facies | ~100% (becomes more recognisable with age) | Broad forehead, periorbital fullness, flat nasal bridge, anteverted nares, long philtrum, full lips, wide mouth, small widely spaced teeth, prominent ears, small chin [1][2] |
| Cardiovascular disease — especially supravalvular aortic stenosis | ~75% [1][2][3] | SVAS is the most common cardiovascular finding; also peripheral pulmonary stenosis, renal artery stenosis, coronary ostial stenosis [2][3] |
| Intellectual disability / developmental delay | ~75% [1][2] | Usually mild-moderate; characteristic profile with preserved language but extreme visuospatial construction deficit [2] |
| Hypercalcaemia | ~15% (hypercalciuria ~30%) [1][2] | Transient neonatal hypercalcaemia; usually returns to normal by 12 months [1]; causes vomiting, feeding difficulties, constipation, prolonged colic [2] |
| Characteristic behavioural phenotype | Very common | Over-friendly manner / "cocktail party" personality, excessive empathy, anxiety, specific phobias, ADHD [1][2] |
| Connective tissue abnormalities | Common | Joint laxity (childhood), hoarse voice, inguinal hernia, kyphoscoliosis [1] |
| Growth failure / short stature | Common | Failure to thrive in infancy; short stature throughout [1][2] |
| Stellate iris pattern | ~50% [1] | Virtually pathognomonic when present in combination with other features |
Key Principle — Why There Are No Strict Diagnostic Criteria
Williams syndrome is diagnosed by genetic testing, not by a clinical score. The clinical features raise suspicion, but the confirmatory test is FISH or chromosomal microarray (CMA) demonstrating hemizygous deletion of the WBSCR at 7q11.23 [1][2]. This is because:
- The phenotype varies in severity — some patients have subtle features
- Atypical deletions (smaller or larger) produce partial phenotypes
- No single clinical feature is 100% specific (though SVAS + elfin facies is highly suggestive)
The following algorithm represents the clinical approach from initial suspicion to confirmed diagnosis and systematic evaluation of complications.
2.1 Step-by-Step Walkthrough of the Algorithm
Step 1 — Clinical Suspicion
- A paediatric geneticist, cardiologist, or general paediatrician notices one or more cardinal features
- The most common triggers are:
- Neonatologist: heart murmur in a newborn + feeding difficulties + hypercalcaemia
- Cardiologist: echocardiographic finding of supravalvular AS → "Is this Williams?"
- Developmental paediatrician: a child with developmental delay + elfin facies + overfriendly behaviour
- General paediatrician: failure to thrive + dysmorphic features
Step 2 — Clinical Assessment
- Systematic dysmorphology examination looking for the cardinal features (facies, growth, behaviour)
- Cardiac auscultation and blood pressure measurement
- Developmental assessment
Step 3 — Genetic Confirmation
- If ≥ 2 cardinal features are present → order genetic testing
- If only 1 feature is present but it is highly specific (e.g., SVAS with suggestive facies) → still reasonable to test
Step 4 — Systematic Evaluation
- Once the diagnosis is confirmed, a comprehensive baseline work-up is required to identify all affected organ systems and guide long-term follow-up (see Section 3 below)
3. Investigation Modalities — Detailed Guide
| Test | Principle | What It Shows | Key Findings in WS | Limitations |
|---|---|---|---|---|
| FISH (Fluorescence In-Situ Hybridisation) | A fluorescently labelled DNA probe complementary to the ELN gene region is hybridised to patient's metaphase chromosomes. Normal: 2 signals (one per chromosome 7). WS: only 1 signal (hemizygous deletion). | Presence or absence of the target region | Only 1 signal at 7q11.23 (confirms hemizygous deletion) | Cannot detect atypical/smaller deletions outside the probe target; cannot detect point mutations; requires dividing cells (metaphase spread) |
| Chromosomal Microarray (CMA) | Array comparative genomic hybridisation (aCGH) or SNP array — scans the entire genome for copy number variations (CNVs) at high resolution | Genome-wide CNV detection with precise breakpoint mapping | 1.5–1.8 Mb deletion at 7q11.23 | More expensive than FISH; may find variants of uncertain significance (VUS) elsewhere |
| MLPA (Multiplex Ligation-dependent Probe Amplification) | Multiple probes targeting specific exons within the WBSCR are used; relative probe signal quantifies copy number | Detects deletions/duplications of individual genes within WBSCR | Confirms deletion and can detect atypical/smaller deletions missed by standard FISH | Does not detect balanced rearrangements |
| Standard Karyotype | G-banded chromosomal analysis at ~5–10 Mb resolution | Gross chromosomal abnormalities | Normal — the 7q11.23 deletion (~1.5 Mb) is too small to be visible on standard karyotype | Cannot diagnose Williams syndrome — this is why FISH or CMA is required |
Why Standard Karyotype Misses Williams Syndrome
A common mistake is to think that a "normal karyotype" excludes a genetic syndrome. The 7q11.23 deletion in Williams syndrome is a microdeletion (~1.5 Mb), well below the ~5–10 Mb resolution of G-banded karyotyping. You must request FISH for ELN/WBSCR or chromosomal microarray specifically. In current clinical practice (2025–2026), CMA is increasingly the first-line genetic test for children with unexplained developmental delay + dysmorphism, as it can detect Williams and many other microdeletion/microduplication syndromes in a single assay.
Which test to order first?
- If high clinical suspicion for Williams syndrome specifically (classic facies + SVAS) → FISH for 7q11.23 is fast, targeted, and relatively inexpensive
- If the presentation is non-specific (developmental delay + dysmorphism but the specific syndrome is unclear) → CMA is preferred as a "catch-all" first-line test that screens for many microdeletion syndromes simultaneously
- Current American College of Medical Genetics (ACMG) and American Academy of Pediatrics (AAP) guidelines recommend CMA as the first-tier genetic test for children with unexplained intellectual disability, developmental delay, or multiple congenital anomalies
Cardiac involvement occurs in ~75% of patients [1][2][3] — cardiovascular evaluation is mandatory at diagnosis and requires ongoing surveillance.
| Investigation | What It Assesses | Key Findings in WS | Why It Matters |
|---|---|---|---|
| Echocardiography (transthoracic) | Cardiac anatomy, valve function, ventricular function, great vessel morphology | Supravalvular aortic stenosis (narrowing at sinotubular junction); peripheral pulmonary stenosis; LV hypertrophy; coronary artery ostial narrowing (difficult to visualise on TTE) | Gold standard for identifying and quantifying the severity of SVAS and PS; guides need for intervention |
| Four-limb blood pressure measurement | Assesses for arterial stenosis and coarctation-like physiology | Hypertension (any limb); BP discrepancy between arms (Coanda effect in SVAS → right arm BP may be higher); upper vs. lower limb gradient if aortic arch involvement | Detects systemic hypertension (from renal artery stenosis [2] or generalised arteriopathy); must use age-, sex-, and height-appropriate paediatric BP percentile tables |
| ECG (12-lead) | Rhythm, axis, chamber hypertrophy, ST-T changes | LV hypertrophy (tall R waves in V5-V6, deep S waves in V1-V2); biventricular hypertrophy if combined SVAS + PS; ST-T changes if myocardial ischaemia (from coronary ostial stenosis) | Baseline and surveillance; important pre-anaesthetic assessment |
| Cardiac catheterisation / angiography | Precise haemodynamic assessment; coronary artery anatomy | Gradient across SVAS; pulmonary artery pressures; coronary artery ostial stenosis (best visualised on aortogram) | Reserved for pre-surgical planning or when echocardiography is inadequate; carries procedural risk |
| CT angiography / MR angiography | Non-invasive vascular imaging | Detailed anatomy of SVAS, aortic arch, branch pulmonary arteries, renal arteries, other systemic arteries | Useful for mapping extent of elastin arteriopathy throughout the body; renal artery stenosis assessment |
Interpreting the echocardiogram — Supravalvular AS grading:
| Severity | Peak Gradient | Clinical Significance |
|---|---|---|
| Mild | < 25 mmHg | Observation; annual echo |
| Moderate | 25–50 mmHg | Closer follow-up (6-monthly); consider surgery if progressive |
| Severe | > 50 mmHg | Surgical intervention usually required (patch aortoplasty or resection) |
Note on paediatric BP interpretation: Normal BP in children is defined by age-, sex-, and height-specific percentile tables. Hypertension = systolic and/or diastolic BP ≥ 95th percentile on ≥ 3 separate occasions. In Williams syndrome, always consider renal artery stenosis [2] as the cause of any hypertension found.
| Investigation | What It Assesses | Key Findings in WS | Interpretation |
|---|---|---|---|
| Serum total and ionised calcium | Calcium homeostasis | Hypercalcaemia (~15%) [1][2]; may be transient (neonatal) or persistent | Total Ca > 2.7 mmol/L in infants (corrected for albumin); ionised Ca > 1.35 mmol/L is more reliable. Usually returns to normal by 12 months [1]; persistent hypercalcaemia warrants further work-up |
| Urine calcium:creatinine ratio | Urinary calcium excretion | Hypercalciuria (~30%) [2] | Normal paediatric UCa:Cr ratio < 0.6 (infants) or < 0.2 (children > 2 years); elevated in WS even when serum Ca normalises |
| Serum phosphate, ALP, 25(OH)D, 1,25(OH)₂D, PTH | Differentiating cause of hypercalcaemia | PTH usually low-normal or suppressed (because hypercalcaemia suppresses PTH); vitamin D metabolites may be elevated | Helps exclude primary hyperparathyroidism (PTH would be elevated); excludes vitamin D intoxication (25(OH)D very high) |
| TSH and free T4 | Thyroid function | Hypothyroidism (~10%) [1][2] — subclinical (elevated TSH, normal fT4) or overt | Screen at diagnosis and annually; paediatric reference ranges vary by age |
| Fasting glucose / HbA1c | Glucose metabolism | Impaired glucose tolerance / diabetes mellitus (more common in adolescents/adults with WS) | Emerges with age; STX1A deletion may contribute |
| Renal function (urea, creatinine, eGFR) | Kidney function | May be abnormal if renal anomalies or nephrocalcinosis | Use paediatric creatinine reference ranges (Schwartz formula for eGFR in children) |
| Investigation | What It Assesses | Key Findings in WS | Why |
|---|---|---|---|
| Renal ultrasound | Renal anatomy, size, echogenicity, collecting system | CAKUT [2] — horseshoe kidney, renal agenesis, duplex system, vesicoureteral reflux; nephrocalcinosis (from hypercalciuria) | Baseline imaging at diagnosis; non-invasive |
| Doppler ultrasound of renal arteries | Renal artery blood flow velocity | Renal artery stenosis [2][3] — elevated peak systolic velocity, tardus-parvus waveform in intrarenal arteries | Screening for renovascular hypertension; if abnormal → consider CTA/MRA for confirmation |
| Urinalysis | Proteinuria, haematuria | May show proteinuria if renal parenchymal involvement | Baseline screening |
| Assessment | What It Measures | Expected Findings in WS |
|---|---|---|
| Developmental screening (e.g., Griffiths, Bayley) | Overall developmental quotient across domains | Developmental delay — motor > language; global but with characteristic dissociation |
| IQ testing (e.g., WISC at school age) | Full-scale, verbal, and performance IQ | Mean IQ ~55–60 (range 40–90); verbal IQ > performance IQ (because language is relatively preserved while visuospatial skills are profoundly impaired) [2] |
| Specific visuospatial testing (e.g., block design, Rey-Osterrieth complex figure) | Visuospatial construction | Extreme deficit [2] — drawings show poor spatial organisation, fragmented copying |
| Adaptive behaviour assessment (e.g., Vineland) | Functional daily living skills | Lower than would be predicted by verbal ability alone — the "cocktail party" verbal fluency masks functional impairment |
| Behavioural assessment (e.g., CBCL, Conners for ADHD) | Behavioural/emotional profile | Overfriendliness, anxiety, specific phobias, ADHD, sleeping difficulties [1][2] |
| Test | What It Measures | Expected Findings |
|---|---|---|
| Brainstem evoked response audiometry (BERA) / OAE (infants) | Hearing thresholds; cochlear and neural function | Sensorineural hearing loss (high-frequency) [2]; or conductive loss from chronic otitis media [1] |
| Pure tone audiometry (older children) | Frequency-specific hearing thresholds | High-tone sensorineural loss; may be progressive |
| Tympanometry | Middle ear function | Type B tympanogram if middle ear effusion (chronic OM) |
| Hyperacusis questionnaire | Sensitivity to sound | Hyperacusis [1] is common and may cause significant distress |
| Test | What It Measures | Expected Findings |
|---|---|---|
| Slit-lamp examination | Iris and anterior segment | Stellate / starry iris pattern (~50%) [1] |
| Visual acuity testing | Refractive errors | Hypermetropia (far-sightedness) is common |
| Cover-uncover test / Hirschberg | Strabismus | Strabismus [2] |
| Fundoscopy | Retina, optic disc | Usually normal; screen for hypertensive retinopathy if hypertensive |
Once the diagnosis is genetically confirmed, a systematic baseline evaluation should be performed. Think of this as screening every organ system that Williams syndrome can affect:
| System | Baseline Investigation | Frequency of Surveillance |
|---|---|---|
| Cardiovascular | Echocardiogram, ECG, 4-limb BP | Echo: 6-monthly to annually (more frequent if moderate-severe lesion); BP: every visit |
| Endocrine — Calcium | Serum Ca²⁺ (total + ionised), urine Ca:Cr ratio | Every 6 months in infancy; annually thereafter; more often if abnormal |
| Endocrine — Thyroid | TSH + fT4 | Annually from diagnosis |
| Renal | Renal US + Doppler, RFT, urinalysis | At diagnosis; repeat if hypertension or abnormal |
| Growth | Height, weight, HC plotted on WS-specific growth charts | Every visit |
| Development | Formal developmental assessment | At diagnosis; regular follow-up with developmental paediatrician |
| Audiology | BERA/OAE (infants); PTA (older children) | At diagnosis; annually or if concerns |
| Ophthalmology | Visual acuity, slit-lamp, strabismus screen | At diagnosis; annually |
| Dental | Dental examination | From eruption of first teeth; regular dental follow-up |
| Musculoskeletal | Clinical assessment for scoliosis, joint laxity | Every visit |
| Behavioural / Psychiatric | Behavioural assessment, screen for anxiety/ADHD | Ongoing; formal assessment at school entry |
5. Interpreting Key Investigation Results — Clinical Scenarios
- Interpretation: Supravalvular aortic stenosis — narrowing at the sinotubular junction, not at the valve itself
- How this differs from valvular AS: No thickened/calcified valve leaflets; no ejection click on auscultation; the stenosis is a discrete or diffuse hourglass narrowing above the valve
- Clinical significance: Grade the severity by peak gradient; if moderate-severe → cardiology follow-up, consider surgical repair
- Why coronary arteries are at risk: The coronaries originate below the stenosis and are exposed to high LV systolic pressure → ostial stenosis, dilation, accelerated atherosclerosis → risk of myocardial ischaemia and sudden cardiac death
- Interpretation: Neonatal hypercalcaemia — this is a recognised feature of WS (~15% [1])
- Next steps: Check ionised Ca²⁺ (more accurate), PTH (expected low/suppressed), 25(OH)D, 1,25(OH)₂D, urine Ca:Cr ratio
- Management: Low-calcium formula, avoid vitamin D supplementation, monitor closely; usually resolves by 12 months [1]
- If persistent: Investigate for other causes (CYP24A1 mutation, primary hyperparathyroidism)
- Interpretation: This is hypertension (> 95th percentile for age/sex/height)
- Most likely cause: Renal artery stenosis [2] due to elastin arteriopathy
- Next steps: Repeat BP on 3 occasions to confirm; Doppler US of renal arteries; if suggestive → CTA or MRA for confirmation
- Treatment: ACE inhibitors or ARBs if renal artery stenosis is unilateral; angioplasty/stenting if severe; avoid ACEi if bilateral RAS (risk of renal failure)
- Interpretation: Hemizygous deletion at 7q11.23 — confirms Williams syndrome
- Next step: Proceed to systematic baseline evaluation (see protocol above)
- Genetic counselling: Most cases de novo [1]; < 5% recurrence risk for future pregnancies (gonadal mosaicism); if parent affected → 50% risk
| Aspect | FISH | CMA |
|---|---|---|
| Scope | Tests one specific locus only (targeted) | Screens entire genome for CNVs |
| Resolution | Can detect the typical ~1.5 Mb WS deletion | Can detect typical AND atypical deletions; provides precise breakpoint data |
| Turnaround | Faster (2–5 days) | Longer (1–3 weeks) |
| Cost | Lower | Higher |
| When to use | High clinical suspicion for a specific syndrome (e.g., classic WS facies) | When the diagnosis is uncertain (child with DD + dysmorphism but syndrome not clinically obvious); first-tier test per ACMG guidelines |
| Additional information | None — binary yes/no for the target region | May reveal other CNVs (incidental findings, VUS); can detect regions of homozygosity (suggesting consanguinity or UPD) |
Current Best Practice — First-Line Genetic Test for DD + Dysmorphism
Per ACMG/AAP guidelines (updated through 2025):
- CMA is the recommended first-tier test for any child with unexplained developmental delay, intellectual disability, autism spectrum disorder, or multiple congenital anomalies
- If CMA is ordered and returns a 7q11.23 deletion, this simultaneously confirms Williams syndrome and screens for other CNVs
- FISH remains useful as a rapid targeted confirmatory test when clinical suspicion is already high
Active Recall - Diagnosis and Investigations of Williams Syndrome
References
[1] Senior notes: Adrian Lui Pediatrics Notes.pdf (p. 514 — Williams Syndrome) [2] Senior notes: MBBS Final MB (Pediatrics) (Felix PY Lai).pdf (p. 878 — Williams Syndrome) [3] Senior notes: Ryan Ho Cardiology.pdf (p. 185 — Common syndromes associated with congenital heart diseases) [5] Lecture slides: GC 151. The malformed child hereditary syndromes and anomalies.pdf (p. 36 — Rare diseases among common diseases)
Management of Williams Syndrome
Williams syndrome is a lifelong, multisystem genetic condition with no cure — the underlying 7q11.23 deletion cannot be corrected. Management is therefore:
- Multidisciplinary and anticipatory — coordinated care across multiple specialties, screening for known complications before they cause harm
- Family-centred — parents/caregivers are central partners; genetic counselling is essential
- Developmentally supportive — early intervention to maximise each child's potential
- System-by-system surveillance — because different complications emerge at different ages
- Lifelong — Williams syndrome is not just a paediatric condition; transition planning to adult services is essential
Management Philosophy — Why Anticipatory Surveillance Matters
Because we know the complications Williams syndrome causes (SVAS in ~75%, hypercalcaemia in ~15%, hypothyroidism in ~10%, renal artery stenosis, hypertension [1][2]), we do not wait for symptoms. We screen proactively at defined intervals so that progressive cardiovascular disease, endocrine dysfunction, or renal complications are caught early — before irreversible damage occurs.
3. Cardiovascular Management
Cardiac involvement occurs in ~75% of patients [1][2][3]. Cardiovascular disease is the leading cause of morbidity and mortality in Williams syndrome.
SVAS is the most common cardiovascular finding [2].
| Severity | Peak Gradient | Management | Rationale |
|---|---|---|---|
| Mild | < 25 mmHg | Conservative: annual echocardiogram, clinical review, 4-limb BP | Most mild SVAS remains stable; no haemodynamic compromise |
| Moderate | 25–50 mmHg | Closer surveillance: 6-monthly echo; consider cardiac catheterisation if progressive | ~20% of moderate SVAS progresses to severe; catheterisation provides precise haemodynamic data and coronary anatomy |
| Severe | > 50 mmHg, or symptomatic (syncope, angina, heart failure), or progressive LVH | Surgical repair | Severe fixed obstruction → LV pressure overload → LVH → risk of myocardial ischaemia, arrhythmia, heart failure, sudden death |
Surgical options for SVAS:
| Technique | Description | When Used |
|---|---|---|
| Patch aortoplasty (single, Y, or extended) | Augmentation of the narrowed sinotubular junction with a patch (autologous pericardium or synthetic material) | Most common approach for discrete SVAS |
| McGoon repair (3-patch technique) | Three separate patches placed into each sinus of Valsalva to enlarge the entire aortic root | Diffuse SVAS or when all 3 sinuses are involved |
| Slide aortoplasty (Brom repair) | The ascending aorta is transected above the stenosis, the distal segment is incised longitudinally in 2 or 3 places and slid down over the proximal segment | Provides excellent geometric reconstruction; increasingly favoured |
| Ross procedure (rare in WS) | Aortic root replacement using pulmonary autograft | Occasionally considered but complicated by the generalised arteriopathy |
Anaesthetic Risk in Williams Syndrome
Williams syndrome patients are at increased risk of sudden cardiac death during anaesthesia and sedation — due to:
- Coronary artery ostial stenosis → myocardial ischaemia under haemodynamic stress
- Biventricular outflow tract obstruction (SVAS + peripheral PS)
- Arrhythmias from ventricular hypertrophy
Pre-anaesthetic checklist (mandatory):
- Recent echocardiogram (within 6–12 months)
- ECG
- 4-limb blood pressure
- Cardiology review
- Anaesthetic management by a paediatric cardiac anaesthetist experienced with WS
- Avoid hypotension (maintain preload); avoid tachycardia (reduces coronary filling time)
- Have resuscitation drugs readily available
- Common in infancy [2]; the branch pulmonary arteries are narrowed by the same elastin arteriopathy
- Natural history: Tends to improve with age as the pulmonary arteries grow — many cases resolve spontaneously by 2–3 years of age
- Management:
- Mild/moderate: Observation; serial echocardiography
- Severe or haemodynamically significant: Balloon angioplasty ± stenting via cardiac catheterisation; rarely requires surgical arterioplasty
- Important to distinguish from isolated valvular PS (as seen in Noonan syndrome) — in WS, the stenosis is in the branch pulmonary arteries, not at the valve
Renal artery stenosis can lead to secondary hypertension [2]. Hypertension may also result from generalised elastin arteriopathy (systemic arterial stenosis/stiffness) [2][3].
Step-by-step approach:
- Detect: Measure 4-limb BP at every clinical visit using age-, sex-, and height-specific paediatric percentile tables
- Hypertension = systolic and/or diastolic BP ≥ 95th percentile on ≥ 3 occasions
- Investigate: If hypertension confirmed →
- Renal Doppler US (screening for renal artery stenosis [2])
- If Doppler suggestive → CTA or MRA for confirmation
- Also check RFT, urinalysis, serum calcium (hypercalcaemia itself can cause hypertension)
- Treat:
| Scenario | First-Line Treatment | Rationale | Cautions |
|---|---|---|---|
| Unilateral renal artery stenosis | ACE inhibitor (e.g., enalapril) or ARB | Reduces RAAS activation caused by renal hypoperfusion | Monitor creatinine and potassium closely after initiation — if creatinine rises > 30% → suspect bilateral RAS or critical unilateral RAS → stop ACEi/ARB |
| Bilateral renal artery stenosis | Calcium channel blocker (e.g., amlodipine) | ACEi/ARBs are contraindicated in bilateral RAS because they remove the angiotensin II–mediated efferent arteriolar constriction that maintains GFR in the stenosed kidney → acute kidney injury | Consider interventional radiology (balloon angioplasty ± stenting) if severe |
| Generalised arteriopathic hypertension (no RAS) | Amlodipine or beta-blocker | Arterial stiffness from elastin deficiency → systolic hypertension | Beta-blockers useful if concurrent LVH |
| Interventional | Balloon angioplasty ± stenting of renal artery | When RAS is severe and/or refractory to medical therapy | Re-stenosis rate is higher in WS due to ongoing arteriopathy |
Paediatric antihypertensive dosing:
| Drug | Paediatric Dose | Formulation |
|---|---|---|
| Enalapril | 0.08–0.1 mg/kg/day, max 0.5 mg/kg/day (max 40 mg/day) | Oral tablet; can be crushed or compounded into liquid |
| Amlodipine | 0.05–0.3 mg/kg/day (max 10 mg/day) | Oral tablet; can be dispersed in water |
| Atenolol | 0.5–1 mg/kg/day (max 2 mg/kg/day) | Oral tablet; liquid formulation available |
- Current AHA/ESC guidelines (2024–2026): Antibiotic prophylaxis is no longer routinely recommended for most congenital heart lesions, including SVAS, unless:
- Prosthetic valve material has been used (e.g., after surgical repair with synthetic patch)
- History of previous infective endocarditis
- Unrepaired cyanotic CHD (not typical for WS)
- Good dental hygiene is emphasised as the primary preventive measure
4. Endocrine and Metabolic Management
Hypercalcaemia (~15%); hypercalciuria (~30%) [1][2]. Associated with vomiting, feeding difficulties, constipation and prolonged colic [2].
| Age Group | Management | Details |
|---|---|---|
| Neonate/infant with symptomatic hypercalcaemia | Dietary: Use low-calcium infant formula (e.g., Calcilo XD by Abbott) — this formula has minimal calcium and no vitamin D; Avoid excessive vitamin D supplementation | Why low-calcium formula? — The hypercalcaemia in WS is thought to involve increased intestinal calcium absorption. Reducing dietary calcium intake lowers the substrate available for absorption |
| Hydration: Ensure adequate fluid intake → promotes renal calcium excretion | Dehydration concentrates calcium; adequate hydration maintains calciuresis | |
| Avoid vitamin D supplementation until calcium normalises | Standard neonatal vitamin D supplementation (400 IU/day) may worsen hypercalcaemia in WS | |
| Severe/symptomatic (Ca²⁺ > 3.5 mmol/L or symptomatic with vomiting, lethargy, seizures): IV normal saline hydration + furosemide (loop diuretic) | Normal saline expands intravascular volume → increases renal Ca²⁺ excretion; furosemide inhibits Ca²⁺ reabsorption in the thick ascending limb of the loop of Henle (NKCC2 cotransporter) | |
| Refractory: Corticosteroids (prednisolone 1–2 mg/kg/day), calcitonin, or bisphosphonates (pamidronate — used with caution in paediatrics) | Corticosteroids reduce intestinal calcium absorption and increase renal excretion; calcitonin inhibits osteoclast activity; bisphosphonates inhibit bone resorption | |
| Infant > 12 months / child | Usually resolves spontaneously by 12 months [1] | Continue monitoring; resume normal calcium intake once serum Ca normalises |
| Ongoing surveillance | Annual serum Ca²⁺ (total + ionised) and urine Ca:Cr ratio, even when normalised | Hypercalcaemia can recur at any age (though rare); hypercalciuria may persist → risk of nephrocalcinosis |
Vitamin D Dilemma in Williams Syndrome
A common clinical challenge: all infants in Hong Kong (and most countries) receive routine vitamin D supplementation (400 IU/day) for rickets prevention. But in WS infants with hypercalcaemia, this may worsen the problem.
- Rule: In WS infants with documented hypercalcaemia → withhold vitamin D supplementation until serum calcium normalises
- Once calcium normalises (usually by ~12 months), standard vitamin D supplementation can be cautiously resumed with monitoring
- Children with WS who are normocalcaemic can receive standard vitamin D doses
| Scenario | Management |
|---|---|
| Overt hypothyroidism (elevated TSH + low fT4) | Levothyroxine replacement at standard paediatric dosing |
| Subclinical hypothyroidism (elevated TSH, normal fT4) | Monitor; treat if TSH persistently > 10 mIU/L or symptoms develop |
| Surveillance | Annual TSH + fT4 from diagnosis, lifelong |
Levothyroxine paediatric dosing:
| Age | Dose |
|---|---|
| Neonates (0–3 months) | 10–15 mcg/kg/day |
| Infants (3–12 months) | 6–8 mcg/kg/day |
| Children (1–5 years) | 5–6 mcg/kg/day |
| Children (6–12 years) | 4–5 mcg/kg/day |
| Adolescents | 2–3 mcg/kg/day |
- Formulation: Oral tablet (can be crushed and given with small amount of water); oral liquid available in some regions
- Monitor TSH + fT4 every 6–8 weeks after dose changes; annually once stable
- Impaired glucose tolerance and overt diabetes mellitus become more common in adolescents and adults with WS
- Surveillance: Fasting glucose or HbA1c from adolescence, repeated every 1–2 years
- Management: Standard diabetes management if diagnosed (lifestyle modification → metformin → insulin as needed)
- Early puberty [1] may occur
- If precocious puberty is confirmed (onset before age 8 in girls or 9 in boys):
- Investigate as per standard protocol (bone age, LH, FSH, oestradiol/testosterone, pelvic/testicular US, brain MRI to exclude central cause)
- Treat with GnRH agonist (e.g., leuprorelin) if central precocious puberty confirmed — to slow skeletal maturation and preserve final adult height
| Issue | Management | Rationale |
|---|---|---|
| Failure to thrive (infancy) [2] | Optimise caloric intake; occupational therapy for oral motor dysfunction; treat GOR if present; manage hypercalcaemia (which causes vomiting/feeding refusal) | Feeding difficulties are multifactorial: hypotonia → poor suck/swallow coordination; hypercalcaemia → vomiting/anorexia; GOR is common |
| Short stature [1][2] | Plot on Williams syndrome-specific growth charts (Morris et al.); exclude hypothyroidism and other treatable causes; ensure adequate nutrition | Using standard growth charts will show consistently low centiles and may trigger unnecessary growth investigations; WS-specific charts provide appropriate reference ranges |
| Growth hormone | Not routinely recommended — GH is sometimes considered in WS children with documented GH deficiency, but data on efficacy and safety are limited | Concern about potential acceleration of cardiovascular disease (arterial wall changes) with GH therapy in WS |
| Dietary considerations | Age-appropriate balanced diet; low calcium diet only if hypercalcaemic — do NOT restrict calcium in normocalcaemic WS children | Unnecessary calcium restriction can cause rickets or osteoporosis |
6. Developmental and Behavioural Management
This is often the area that has the greatest impact on quality of life for the child and family.
| Domain | Intervention | Why |
|---|---|---|
| Gross motor | Physiotherapy from infancy | Hypotonia delays motor milestones; physiotherapy builds strength, balance, and coordination |
| Fine motor / visuospatial | Occupational therapy (OT) | Extreme visuospatial construction deficit [2] → OT uses compensatory strategies; teach through verbal-auditory strengths rather than visual-spatial tasks |
| Language / speech | Speech and language therapy | Although language is relatively preserved, articulation, pragmatics, and comprehension still benefit from therapy; hoarse voice [2] may need voice therapy |
| Feeding | Feeding therapy (OT or SLT) | Oral motor dysfunction in infancy; tongue thrusting, poor chewing |
| Strategy | Detail |
|---|---|
| Special educational needs (SEN) assessment | Most children require SEN placement or support within mainstream education |
| Verbal-auditory learning strategies | Because visuospatial skills are severely impaired but verbal skills are relatively preserved, teaching should leverage auditory and verbal channels (stories, songs, verbal instructions) rather than diagrams, maps, or spatial tasks |
| Individualised education programme (IEP) | Tailored academic goals; additional classroom support |
| Issue | Management |
|---|---|
| Overfriendliness / social vulnerability [1][2] | Social skills training — teach appropriate social boundaries; stranger awareness programmes; safeguarding measures (the overfriendly nature puts children at risk of exploitation) |
| Anxiety and specific phobias [2] | Cognitive behavioural therapy (CBT) adapted for cognitive level; desensitisation for phobias (especially noise phobia/hyperacusis); anxiolytic medication (SSRIs) only if severe and refractory |
| ADHD [2] | Standard ADHD management: behavioural strategies first-line; methylphenidate if medication needed (start low, titrate slowly; monitor cardiovascular status carefully given underlying cardiac disease) |
| Sleeping difficulties [2] | Sleep hygiene measures; melatonin (0.5–5 mg at bedtime) — commonly used and generally safe in paediatrics for circadian rhythm disturbance |
ADHD Medication + Cardiac Disease — A Careful Balance
Stimulant medications (methylphenidate, dexamfetamine) can increase heart rate and blood pressure. In Williams syndrome patients with:
- SVAS → increased afterload risk
- Coronary ostial stenosis → ischaemic risk with tachycardia
- Pre-existing hypertension → may worsen
Rule: Before starting stimulant medication in a WS child, obtain a recent echocardiogram, ECG, and BP measurement. Monitor cardiovascular parameters regularly. Use the lowest effective dose. Non-stimulant alternatives (atomoxetine, guanfacine) may be preferred if cardiac concerns are significant.
| Issue | Management | Rationale |
|---|---|---|
| Renal artery stenosis [2][3] | Antihypertensives ± angioplasty (see Section 3.3) | Elastin arteriopathy |
| CAKUT [2] | Manage per specific anomaly (e.g., VUR prophylaxis, monitoring for UTIs) | Structural anomalies may predispose to infection or obstruction |
| Nephrocalcinosis | Ensure adequate hydration; treat hypercalciuria; avoid excessive calcium/vitamin D | Chronic hypercalciuria → calcium deposition in renal parenchyma → progressive renal damage |
| Bladder dysfunction | Urotherapy; timed voiding; anticholinergics if overactive bladder | Enuresis and daytime incontinence are common; connective tissue laxity may contribute to bladder dysfunction |
| Issue | Management |
|---|---|
| Chronic otitis media [1] | Standard management: watchful waiting → antibiotics for acute OM → grommet insertion if recurrent/chronic OME with hearing loss |
| Sensorineural hearing loss (high-frequency) [2] | Hearing aids if moderate-severe; regular audiological follow-up |
| Hyperacusis [1] | Desensitisation therapy (gradual exposure to tolerable sound levels); noise-dampening earplugs/headphones for distressing situations; reassurance and education |
| Issue | Management |
|---|---|
| Strabismus [2] | Orthoptic assessment; patching; surgical correction if significant |
| Refractive errors | Corrective lenses |
| Hypertensive retinopathy | Treat hypertension; fundoscopic monitoring |
Dental problems including microdontia, enamel hypoplasia, malocclusion, excessive interdental spacing [2].
| Issue | Management |
|---|---|
| Enamel hypoplasia | Fluoride varnish; sealants; careful dental hygiene education |
| Malocclusion | Orthodontic referral |
| Dental caries risk | Regular dental review (every 6 months); fluoride supplementation where appropriate |
| Anaesthetic considerations | Dental procedures requiring sedation/GA must follow the WS anaesthetic precautions (see Section 3.1) |
| Issue | Management |
|---|---|
| Kyphoscoliosis [1] | Physiotherapy; orthopaedic monitoring; bracing if progressive; surgical correction rarely needed |
| Joint hypermobility (childhood) | Physiotherapy for joint stability; supportive footwear |
| Joint contractures (adolescence/adulthood) | Stretching; physiotherapy; OT for adaptive devices |
| Scenario | Counselling |
|---|---|
| De novo deletion (majority) [1] | Parents are NOT carriers; recurrence risk is < 5% (accounting for possible gonadal mosaicism). Reassurance that this was a random event during meiosis |
| Affected parent | 50% risk to each offspring (autosomal dominant). Offer prenatal diagnosis (chorionic villus sampling at 11–13 weeks or amniocentesis at 15–18 weeks with FISH/CMA for 7q11.23) |
| Affected individual reaching reproductive age | Discuss 50% transmission risk; offer preimplantation genetic testing (PGT) if IVF considered; non-directive counselling |
Williams syndrome is a lifelong condition. Paediatric services must plan transition to adult care:
| Aspect | Details |
|---|---|
| Timing | Begin transition planning at 14–16 years; complete by 18–25 years |
| Adult medical care | Ongoing cardiology surveillance (SVAS can progress into adulthood); endocrine monitoring; BP monitoring; metabolic screening |
| Psychosocial | Supported living arrangements (most adults with WS require some level of support); vocational training; social skills support; legal capacity assessment |
| Mental health | Anxiety disorders are common in adults with WS; ongoing psychiatric/psychological support |
| Life expectancy | Shorter life expectancy ~60 years [6] — primarily due to cardiovascular complications |
| Age | Key Actions |
|---|---|
| Diagnosis | Baseline echo, ECG, 4-limb BP; serum Ca²⁺ + urine Ca:Cr; TSH/fT4; renal US + Doppler; RFT/urinalysis; audiology; ophthalmology; developmental assessment; dental assessment; genetic counselling |
| 0–12 months | 6-monthly echo (if cardiac lesion); serial calcium monitoring; feeding support; early intervention enrolment |
| 1–5 years | Annual echo (or more frequent if moderate-severe lesion); annual TSH, calcium, BP; developmental review; audiology; ophthalmology |
| 5–12 years | Annual echo, BP, TSH, calcium; educational support review; behavioural assessment (ADHD, anxiety); scoliosis screening |
| 12–18 years | Annual echo, BP, TSH, calcium; fasting glucose/HbA1c (start in adolescence); pubertal assessment; transition planning |
| > 18 years | Lifelong cardiology, endocrine, renal surveillance; mental health support; vocational support |
| Incorrect Action | Why It Is Wrong |
|---|---|
| Restricting calcium in all WS patients | Only restrict calcium if hypercalcaemic; normocalcaemic patients need normal calcium intake for bone health |
| Giving standard vitamin D doses to a hypercalcaemic WS infant | May worsen hypercalcaemia — withhold until calcium normalises |
| Ignoring cardiovascular assessment before any sedation | Risk of sudden cardiac death — always obtain pre-anaesthetic cardiac review |
| Using standard growth charts as the sole reference | WS children will always track low; use WS-specific growth charts to avoid unnecessary investigation for "failure to thrive" |
| Treating ADHD with stimulants without cardiac evaluation | Risk of cardiovascular complications in a child with SVAS and/or coronary disease |
High Yield Summary — Management of Williams Syndrome
- No cure — management is multidisciplinary, anticipatory, and lifelong
- Cardiovascular (greatest source of morbidity/mortality):
- SVAS: Mild → observe; moderate → close surveillance; severe → surgical repair (patch aortoplasty, slide aortoplasty)
- Peripheral PS: Often improves with age; balloon angioplasty if severe
- Hypertension: Investigate for renal artery stenosis [2]; treat with ACEi (if unilateral RAS) or CCB (if bilateral); angioplasty if refractory
- Pre-anaesthetic cardiac review mandatory — risk of sudden cardiac death
- Endocrine:
- Hypercalcaemia: Low-calcium formula in infancy; avoid vitamin D if hypercalcaemic; IV NS + furosemide if severe; usually resolves by 12 months [1]
- Hypothyroidism: Levothyroxine replacement; annual screening
- Development: Early intervention (physio, OT, SLT); leverage verbal-auditory strengths; SEN support
- Behaviour: Social skills training for overfriendliness/safeguarding; CBT/SSRIs for anxiety; melatonin for sleep; methylphenidate for ADHD (with cardiac precautions)
- Growth: WS-specific growth charts; optimise nutrition; GH not routinely recommended
- Renal: Monitor for RAS, CAKUT, nephrocalcinosis
- Genetic counselling: De novo ~95%, < 5% recurrence; 50% if parent affected
- Shorter life expectancy ~60 years [6] — cardiovascular disease is the main determinant
Active Recall - Management of Williams Syndrome
References
[1] Senior notes: Adrian Lui Pediatrics Notes.pdf (p. 514 — Williams Syndrome) [2] Senior notes: MBBS Final MB (Pediatrics) (Felix PY Lai).pdf (p. 878 — Williams Syndrome) [3] Senior notes: Ryan Ho Cardiology.pdf (p. 185 — Common syndromes associated with congenital heart diseases) [6] Senior notes: Maksim Paediatric Notes.pdf (p. 206 — Williams syndrome)
Complications of Williams Syndrome
Complications in Williams syndrome arise from two fundamental mechanisms:
- Elastin arteriopathy — the haploinsufficiency of the ELN gene produces a generalised vasculopathy affecting any artery [2][3]. This single mechanism drives the majority of the serious, life-threatening complications.
- Contiguous gene effects — the ~26–28 other deleted genes produce neurocognitive, endocrine, connective tissue, and growth-related complications that accumulate over a lifetime.
Because Williams syndrome is lifelong, complications evolve with age — some are prominent in infancy (hypercalcaemia, feeding difficulties, peripheral PS), others emerge later (hypertension, diabetes, progressive SVAS, anxiety disorders). Understanding this temporal pattern is essential for anticipatory surveillance.
2. Cardiovascular Complications
Cardiovascular disease is the leading cause of morbidity and mortality and the principal determinant of shorter life expectancy (~60 years) [6].
- Supravalvular AS is the most common cardiovascular finding [2]
- Why it progresses: With ongoing growth, the aortic wall at the sinotubular junction continues to thicken due to smooth muscle hyperplasia and collagen deposition compensating for elastin deficiency. The stenosis does not self-correct — unlike peripheral PS, which may improve as pulmonary arteries grow.
- Consequences of progressive SVAS:
| Consequence | Mechanism |
|---|---|
| Left ventricular hypertrophy (LVH) | Chronic pressure overload → concentric LVH (wall thickens to generate more force against increased afterload) |
| Left ventricular failure | Prolonged LVH eventually leads to diastolic dysfunction (stiff, non-compliant ventricle) and ultimately systolic failure |
| Aortic regurgitation | Structural distortion of the aortic root from the stenotic segment can affect valve coaptation |
| Post-stenotic aortic dilation | Turbulent jet beyond the stenosis → localised aortic wall stress and dilation (less common in WS than in valvular AS because the arterial wall is stiff from elastin deficiency) |
Coronary artery ostial stenosis [3] — this is the most feared cardiovascular complication.
Why does this happen?
- The coronary arteries originate from the aortic sinuses of Valsalva, which are below the supravalvular stenosis
- The coronary ostia are embedded within the thickened, elastin-deficient aortic wall
- As the sinotubular junction narrows, the coronary ostia become progressively encroached upon
- Additionally, the coronary arteries are exposed to high LV systolic pressure (because they arise proximal to the obstruction), causing:
- Coronary artery dilation and tortuosity
- Accelerated atherosclerosis
- Intimal thickening at the ostia
| Complication | Clinical Manifestation | Risk Setting |
|---|---|---|
| Myocardial ischaemia | Chest pain, ST-T changes on ECG, troponin elevation | Exercise, stress, anaesthesia |
| Myocardial infarction | Acute chest pain, haemodynamic collapse | Can occur even in childhood |
| Sudden cardiac death | Cardiac arrest, ventricular fibrillation | Especially during anaesthesia/sedation — the combination of reduced afterload (anaesthetic agents) + fixed coronary obstruction + tachycardia (reduced diastolic filling time) is lethal |
Sudden Cardiac Death — The Most Critical Complication
The risk of sudden cardiac death in Williams syndrome is estimated at approximately 1 in 1,000 per year — significantly higher than the general paediatric population. The risk is highest in patients with:
- Severe biventricular outflow tract obstruction (SVAS + peripheral PS)
- Coronary artery ostial stenosis
- During anaesthesia or sedation — multiple case reports document cardiac arrest during routine dental or diagnostic procedures
This is why every anaesthetic encounter must include pre-procedure cardiac evaluation (echocardiogram, ECG, cardiology review) and be performed by an experienced paediatric cardiac anaesthetist [3].
Stenosis of arterial system — systemic arterial stenosis, renal artery stenosis [3].
The generalised elastin arteriopathy means that any medium or large artery in the body can develop stenosis. This produces a range of secondary complications:
| Artery Affected | Complication | Mechanism | Clinical Consequence |
|---|---|---|---|
| Renal arteries [2][3] | Secondary hypertension | Renal artery stenosis → reduced renal perfusion → RAAS activation → ↑ angiotensin II → vasoconstriction + aldosterone secretion → salt/water retention + ↑ SVR | Systemic hypertension; if untreated → LVH (on top of SVAS-induced LVH), hypertensive nephropathy, hypertensive retinopathy, stroke |
| Mesenteric arteries | Mesenteric ischaemia | Narrowing of coeliac/SMA/IMA → reduced gut perfusion | Postprandial abdominal pain ("intestinal angina"); rarely, bowel infarction |
| Cerebral arteries | Cerebrovascular stenosis | Intracranial arterial narrowing → reduced cerebral perfusion | Stroke (rare in children, more common in adults); moyamoya-like disease has been described |
| Aorta (beyond sinotubular junction) | Coarctation-like narrowing | Elastin deficiency in mid-aortic segment | "Middle aortic syndrome" → upper/lower limb BP gradient; severe hypertension |
| Peripheral arteries | Claudication, limb ischaemia | Stenosis of iliac, femoral, or other limb arteries | Rare in childhood; may manifest in adulthood |
Hypertension prevalence: Up to 50–60% of adolescents and adults with WS have hypertension — this is far higher than the ~15% figure for hypercalcaemia, making hypertension one of the most common ongoing complications to monitor.
Peripheral pulmonary stenosis common in infancy [2].
- In most cases, PPS improves with age as the pulmonary arteries grow relative to body size
- Complications of severe PPS:
- Right ventricular pressure overload → RVH → right heart failure
- Unequal pulmonary blood flow → ventilation-perfusion mismatch → hypoxaemia
- Combined with SVAS → biventricular outflow tract obstruction → highest risk of haemodynamic collapse
- Arise secondary to:
- Ventricular hypertrophy (LVH from SVAS, RVH from PPS) → altered conduction substrate → re-entry circuits
- Myocardial fibrosis from chronic pressure overload
- Coronary ischaemia → ischaemic arrhythmias
- Can manifest as ventricular tachycardia, ventricular fibrillation, or sudden cardiac death
3. Endocrine and Metabolic Complications
Hypercalcaemia (~15%) and hypercalciuria (~30%) [1][2]. Associated with vomiting, feeding difficulties, constipation and prolonged colic [2].
| Complication | Mechanism | Age |
|---|---|---|
| Feeding difficulties / failure to thrive | Hypercalcaemia → anorexia, nausea, vomiting; also decreases GI motility → constipation | Infancy |
| Nephrocalcinosis | Chronic hypercalciuria → calcium salt precipitation in renal parenchyma | Any age (even after serum Ca normalises, if hypercalciuria persists) |
| Renal stones (nephrolithiasis) | Same mechanism — supersaturation of calcium in urine | Childhood–adulthood |
| Nephrogenic diabetes insipidus | Ca²⁺ interferes with aquaporin-2 (AQP2) expression in the collecting duct → impaired water reabsorption → polyuria, polydipsia | If hypercalcaemia is severe or prolonged |
| Constipation | Hypercalcaemia → decreased smooth muscle contractility in the GI tract → reduced peristalsis | Infancy |
| Cardiac effects | Hypercalcaemia → shortened QT interval on ECG → at extreme levels, risk of cardiac arrest | Neonatal (if very severe) |
Important nuance: Even when serum calcium normalises (usually by 12 months [1]), hypercalciuria may persist in ~30% [2]. This silent hypercalciuria drives ongoing renal complications (nephrocalcinosis, stones) even when clinicians believe the calcium problem has "resolved." This is why urine Ca:Cr monitoring must continue beyond infancy.
- May present as subclinical (elevated TSH, normal fT4) or overt (elevated TSH, low fT4)
- Consequences if untreated:
- In young children: Worsens developmental delay, lethargy, constipation, weight gain, growth deceleration — all of which may be mistakenly attributed to WS itself rather than treatable hypothyroidism
- In adolescents/adults: Fatigue, depression, dyslipidaemia, weight gain
- Key point: Because many symptoms of hypothyroidism overlap with WS features (short stature, developmental delay, constipation), hypothyroidism may be missed unless systematically screened with annual TSH + fT4
- Prevalence increases with age — up to 35–40% of adults with WS have impaired glucose tolerance, and ~15% develop overt type 2 diabetes mellitus
- Mechanism: Likely related to STX1A deletion (syntaxin 1A — involved in insulin vesicle exocytosis from beta cells) + obesity risk + reduced physical activity
- Complications: Standard diabetic complications (retinopathy, nephropathy, neuropathy, cardiovascular disease) — compounded by the pre-existing arteriopathy
Early puberty [1].
- Central precocious puberty → if untreated:
- Accelerated skeletal maturation → premature epiphyseal fusion → compromised final adult height (already reduced in WS)
- Psychosocial consequences of early pubertal development in a child with intellectual disability
4. Neurocognitive and Behavioural Complications
Developmental delay and intellectual disability (~75%): usually mild-moderate [1].
- Extreme deficits in visuospatial construction [2] → difficulty with mathematics, science, map reading, handwriting, design tasks
- The verbal-performance IQ discrepancy can mislead teachers and parents into overestimating the child's overall ability based on their verbal fluency
| Complication | Prevalence | Mechanism | Clinical Significance |
|---|---|---|---|
| Anxiety disorders [2] | ~50–60% of children and adults | Generalised anxiety, specific phobias (especially noise phobia related to hyperacusis [1]), social anxiety (paradoxically, despite overfriendliness) | Can be severely debilitating; often the most distressing problem for families |
| Depression | Common in adolescents/adults | Increasing awareness of social difficulties + limited independence + social isolation | May be underdiagnosed due to communication limitations |
| ADHD [2] | ~60–80% | Executive function deficits | Affects learning, behaviour management, and safety |
| Sleeping difficulties [2] | Very common | Anxiety + possible melatonin dysregulation | Disrupts family function; worsens daytime behaviour |
| Obsessive-compulsive features | Some patients | Related to anxiety spectrum | Repetitive questioning, routines |
Overfriendliness / "cocktail party" personality [1][2].
- The hallmark behavioural feature of WS is the indiscriminate approach to strangers — intense eye contact, verbal engagement, physical proximity
- Why is this a complication? Because it creates:
- Safeguarding risk — children and adolescents with WS are vulnerable to exploitation, abuse, and manipulation by strangers
- Difficulty forming deep friendships — the social approach is superficial; children with WS struggle with reciprocity, turn-taking, and reading social cues
- Social isolation in adulthood — peers find the overfriendliness inappropriate; individuals with WS often have few genuine friendships
| Complication | Mechanism | Consequence |
|---|---|---|
| Renal artery stenosis [2][3] | Elastin arteriopathy → narrowing of renal artery | Secondary hypertension → LVH, hypertensive nephropathy, stroke risk |
| Nephrocalcinosis | Chronic hypercalciuria → calcium deposition in renal parenchyma | Progressive renal impairment; may cause recurrent UTIs |
| Nephrolithiasis | Calcium supersaturation in urine | Renal colic; obstruction; infection |
| CAKUT [2] | Congenital anomalies (horseshoe kidney, VUR, duplex, agenesis) | Recurrent UTIs; CKD if severe |
| Bladder dysfunction | Connective tissue laxity + possible neurogenic component | Enuresis; urinary incontinence; recurrent UTIs |
| Chronic kidney disease | Cumulative effect of RAS + nephrocalcinosis + CAKUT + hypertensive nephropathy | Progressive renal failure; may require dialysis in severe cases (rare) |
| Complication | Mechanism | Age |
|---|---|---|
| Failure to thrive [2] | Feeding difficulties (oral motor dysfunction, hypotonia, GOR) + hypercalcaemia (vomiting, anorexia) + caloric insufficiency | Infancy |
| Short stature [1][2] | Intrinsic growth pattern of WS + possible endocrine factors (hypothyroidism, early puberty → premature fusion) + nutritional insufficiency in infancy | Lifelong |
| Obesity | Reduced physical activity (hypotonia, joint problems, cognitive limitations) + food as comfort/social behaviour | School age–adulthood |
| Gastro-oesophageal reflux | Lower oesophageal sphincter hypotonia (connective tissue laxity); feeding difficulties | Infancy–early childhood |
| Chronic constipation | Smooth muscle hypotonia (connective tissue component) + hypercalcaemia + dietary factors | Any age |
Hearing impairment: chronic otitis media, hyperacusis [1]. Sensorineural (high-tone) or conductive hearing loss [2].
| Complication | Mechanism | Consequence |
|---|---|---|
| Chronic/recurrent otitis media | Eustachian tube dysfunction (possibly related to craniofacial anatomy) | Conductive hearing loss; language delay; recurrent infections requiring antibiotics or grommets |
| Progressive sensorineural hearing loss | Cochlear changes (mechanism not fully understood — possibly related to connective tissue changes in the organ of Corti) | Insidious high-frequency hearing loss → difficulty hearing consonants → impacts speech comprehension |
| Hyperacusis [1] | Altered central auditory processing → heightened sensitivity to ordinary environmental sounds | Distress, avoidance behaviours, noise phobia → can be severely limiting (child refuses to attend noisy environments → school assemblies, birthday parties) |
| Complication | Mechanism | Age Pattern |
|---|---|---|
| Kyphoscoliosis [1] | Connective tissue laxity from elastin deficiency → poor spinal ligament support | Childhood; may progress in adolescence |
| Joint hypermobility → contractures | Childhood: laxity from elastin deficiency; Adulthood: compensatory muscle tightening → progressive joint contractures | Hypermobility in childhood transitions to contractures in adolescence/adulthood (a classic pattern in WS) |
| Inguinal and umbilical hernias | Connective tissue weakness in the abdominal wall | Infancy–childhood |
| Rectal prolapse | Connective tissue laxity of pelvic floor | Rare; childhood |
| Pes planus (flat feet) | Ligamentous laxity | Childhood |
Dental problems including microdontia, enamel hypoplasia, malocclusion, excessive interdental spacing [2].
- Enamel hypoplasia → increased caries susceptibility
- Malocclusion → difficulty chewing; cosmetic concerns
- Small teeth with wide spacing → cosmetic and functional impact
- Dental procedures carry increased risk due to the need for sedation/GA and the associated cardiac risks (see cardiovascular complications)
| Complication | Detail |
|---|---|
| Strabismus [2] | May cause amblyopia if not corrected early → permanent visual loss in the deviated eye |
| Hypermetropia | Common refractive error; corrected with glasses |
| Hypertensive retinopathy | Secondary to systemic hypertension — fundoscopic changes (arteriolar narrowing, AV nipping, haemorrhages, papilloedema in severe cases) |
| Age | Key Complications to Watch For |
|---|---|
| Neonate | Hypercalcaemia, feeding difficulties, cardiac murmur (PPS > SVAS at this age), prolonged jaundice |
| Infant (1–12 months) | Failure to thrive, GOR, constipation, persistent hypercalcaemia, PPS haemodynamic significance |
| Toddler (1–3 years) | SVAS progression, developmental delay becoming apparent, hypercalcaemia usually resolving |
| Preschool (3–5 years) | Visuospatial deficits identified; behavioural problems (overfriendliness, anxiety, ADHD); scoliosis screening |
| School age (5–12 years) | Academic difficulties; behavioural/mental health (anxiety, phobias, ADHD); hypertension emerging; progressive SVAS; hypothyroidism |
| Adolescence (12–18 years) | Hypertension (up to 50%); glucose intolerance; early puberty; obesity; mental health (depression, anxiety); joint contractures replacing hypermobility; transition planning |
| Adulthood (> 18 years) | Progressive SVAS; coronary disease; hypertension; DM; CKD; hearing loss; depression/anxiety; social isolation; reduced life expectancy |
Shorter life expectancy ~60 years [6].
| Factor | Impact on Prognosis |
|---|---|
| Severity of SVAS | The most important single prognostic factor; severe SVAS requiring surgery or causing LV failure shortens life significantly |
| Coronary artery disease | Sudden cardiac death risk; myocardial infarction |
| Hypertension | Accelerates end-organ damage (cardiac, renal, cerebrovascular) |
| Renal disease | CKD from combined RAS + nephrocalcinosis + hypertensive nephropathy |
| Quality of multidisciplinary care | Early and consistent surveillance with proactive management of complications substantially improves outcomes |
High Yield Summary — Complications of Williams Syndrome
Cardiovascular (greatest source of mortality):
- Progressive SVAS → LVH → heart failure [2][3]
- Coronary artery ostial stenosis → myocardial ischaemia → sudden cardiac death (especially under anaesthesia) [3]
- Renal artery stenosis → secondary hypertension [2][3]
- Systemic arterial stenosis (any artery) → mesenteric ischaemia, cerebrovascular stenosis, middle aortic syndrome [3]
- Peripheral PS → usually improves; severe cases → RV failure [2]
Endocrine/Metabolic:
- Hypercalcaemia → feeding difficulties, constipation, nephrocalcinosis, nephrolithiasis [1][2]
- Hypothyroidism → worsens developmental delay if undetected [1][2]
- Impaired glucose tolerance / DM (adolescence/adulthood)
- Early puberty → compromised final height [1]
Neurocognitive/Behavioural:
- Intellectual disability (mild-moderate, ~75%) with extreme visuospatial deficit [1][2]
- Anxiety disorders, phobias (noise), depression, ADHD [2]
- Social vulnerability from overfriendliness [1][2]
Renal: Nephrocalcinosis, nephrolithiasis, CAKUT, CKD [2] Hearing: Progressive SNHL, chronic OM, hyperacusis [1][2] MSK: Kyphoscoliosis, joint contractures [1] Growth: FTT, short stature, obesity [1][2] Life expectancy: ~60 years [6]
Active Recall - Complications of Williams Syndrome
References
[1] Senior notes: Adrian Lui Pediatrics Notes.pdf (p. 514 — Williams Syndrome) [2] Senior notes: MBBS Final MB (Pediatrics) (Felix PY Lai).pdf (p. 878 — Williams Syndrome) [3] Senior notes: Ryan Ho Cardiology.pdf (p. 185 — Common syndromes associated with congenital heart diseases) [5] Lecture slides: GC 151. The malformed child hereditary syndromes and anomalies.pdf (p. 36 — Rare diseases among common diseases) [6] Senior notes: Maksim Paediatric Notes.pdf (p. 206 — Williams syndrome)
High Yield Summary
Williams Syndrome — Key Facts for Exams:
- 7q11.23 microdeletion including the elastin (ELN) gene — majority de novo [1][2]
- Elfin facies: broad forehead, periorbital fullness, flat nasal bridge, anteverted nares, long philtrum, full lips, wide mouth, small widely spaced teeth, prominent ears, stellate iris [1][2]
- Supravalvular aortic stenosis — most common and most characteristic cardiac lesion [2][3]
- Peripheral pulmonary stenosis — common in infancy, often improves [2]
- Elastin arteriopathy → any artery can be affected → renal artery stenosis → hypertension [2][3]
- Coronary ostial stenosis → risk of sudden cardiac death (especially under anaesthesia)
- Intellectual disability (75%, mild-moderate) with characteristic profile: preserved language, extreme visuospatial deficit [1][2]
- Overfriendly / "cocktail party" personality — pathognomonic behavioural phenotype [1][2]
- Hypercalcaemia (~15%) — transient neonatal, causes feeding difficulties and colic; hypercalciuria (~30%) [1][2]
- Hypothyroidism (~10%) [1][2]; early puberty [1]
- Short stature / failure to thrive [1][2]
- Hyperacusis and sensorineural/conductive hearing loss [1][2]
- Diagnosis by FISH or chromosomal microarray (CMA) — not visible on standard karyotype
- Associations to remember: WILLIAMS = Wide mouth, Increased Ca²⁺, Long philtrum, Learning difficulties, Iris (stellate), Aortic stenosis (supravalvular), Mental retardation, Small stature/teeth
High Yield Summary — Differential Diagnosis of Williams Syndrome
When to suspect Williams syndrome over mimics:
- Supravalvular AS is virtually pathognomonic — no other common syndrome produces it [2][3]
- Elfin facies + hypercalcaemia + overfriendliness = Williams until proven otherwise [1][2]
- Calcium direction distinguishes WS (↑Ca²⁺) from DiGeorge (↓Ca²⁺)
- Cardiac lesion type distinguishes all major syndromes: SVAS = Williams, AVSD = Down, valvular PS = Noonan, coarctation = Turner, conotruncal = DiGeorge [1][3][5][6]
- The GC lecture groups Williams with 22q11.2 deletion, Marfan, Noonan, Loeys-Dietz, and Long QT as "rare diseases among common diseases" [5] — know all their cardiac associations
- Familial isolated SVAS (ELN point mutations) is the closest genetic differential — same cardiac lesion but no dysmorphism, cognitive, or behavioural features
High Yield Summary — Management of Williams Syndrome
- No cure — management is multidisciplinary, anticipatory, and lifelong
- Cardiovascular (greatest source of morbidity/mortality):
- SVAS: Mild → observe; moderate → close surveillance; severe → surgical repair (patch aortoplasty, slide aortoplasty)
- Peripheral PS: Often improves with age; balloon angioplasty if severe
- Hypertension: Investigate for renal artery stenosis [2]; treat with ACEi (if unilateral RAS) or CCB (if bilateral); angioplasty if refractory
- Pre-anaesthetic cardiac review mandatory — risk of sudden cardiac death
- Endocrine:
- Hypercalcaemia: Low-calcium formula in infancy; avoid vitamin D if hypercalcaemic; IV NS + furosemide if severe; usually resolves by 12 months [1]
- Hypothyroidism: Levothyroxine replacement; annual screening
- Development: Early intervention (physio, OT, SLT); leverage verbal-auditory strengths; SEN support
- Behaviour: Social skills training for overfriendliness/safeguarding; CBT/SSRIs for anxiety; melatonin for sleep; methylphenidate for ADHD (with cardiac precautions)
- Growth: WS-specific growth charts; optimise nutrition; GH not routinely recommended
- Renal: Monitor for RAS, CAKUT, nephrocalcinosis
- Genetic counselling: De novo ~95%, < 5% recurrence; 50% if parent affected
- Shorter life expectancy ~60 years [6] — cardiovascular disease is the main determinant
High Yield Summary — Complications of Williams Syndrome
Cardiovascular (greatest source of mortality):
- Progressive SVAS → LVH → heart failure [2][3]
- Coronary artery ostial stenosis → myocardial ischaemia → sudden cardiac death (especially under anaesthesia) [3]
- Renal artery stenosis → secondary hypertension [2][3]
- Systemic arterial stenosis (any artery) → mesenteric ischaemia, cerebrovascular stenosis, middle aortic syndrome [3]
- Peripheral PS → usually improves; severe cases → RV failure [2]
Endocrine/Metabolic:
- Hypercalcaemia → feeding difficulties, constipation, nephrocalcinosis, nephrolithiasis [1][2]
- Hypothyroidism → worsens developmental delay if undetected [1][2]
- Impaired glucose tolerance / DM (adolescence/adulthood)
- Early puberty → compromised final height [1]
Neurocognitive/Behavioural:
- Intellectual disability (mild-moderate, ~75%) with extreme visuospatial deficit [1][2]
- Anxiety disorders, phobias (noise), depression, ADHD [2]
- Social vulnerability from overfriendliness [1][2]
Renal: Nephrocalcinosis, nephrolithiasis, CAKUT, CKD [2] Hearing: Progressive SNHL, chronic OM, hyperacusis [1][2] MSK: Kyphoscoliosis, joint contractures [1] Growth: FTT, short stature, obesity [1][2] Life expectancy: ~60 years [6]

Memory palace hooks for Williams Syndrome
How to Use This Memory Palace
Each numbered symbol is a recall hook mapped back to this page's own notes. The Note concept column is the source of truth; the symbol logic explains why the visual cue should trigger that concept.
This first pass maps the supplied Williams syndrome labels 28-54. Any additional labels visible in the image should be added only after they are tied back to the MBBSPedia note sections.
Feature Guardrail
The supplied Sketchy nose hook is a Williams facial-feature cue, but this page's note wording lists a flat nasal bridge with anteverted nares rather than a DiGeorge-like bulbous nasal tip. Use the Note concept column as the source of truth when recalling facial findings.
| No. | Symbol | Source tab | Note concept | Etymology / symbol logic |
|---|---|---|---|---|
| 28 | Governor Williams with "7q11.23" | Etiology / Summary | Williams syndrome is caused by a hemizygous microdeletion at 7q11.23, including the elastin gene. | Governor Williams anchors the syndrome name; 7q11.23 is the chromosomal address. |
| 29 | Irritable Governor Williams | Etiology | Infants may have irritability, excessive crying, colic, and distress from hypercalcaemia or hyperacusis. | The irritable governor turns early nonspecific crying into a Williams clue. |
| 30 | Vomiting figure with raised milk bottle | Etiology / Dx / Mx | Transient neonatal hypercalcaemia can cause vomiting, feeding difficulties, constipation, and prolonged colic. | Milk cues calcium; the raised bottle cues high calcium rather than low calcium. |
| 31 | Food falling | Etiology / Mx / Complications | Feeding difficulties and failure to thrive are common in infancy from oral motor dysfunction, hypotonia, GOR, and hypercalcaemia. | Food that cannot be held down cues vomiting, poor intake, and poor weight gain. |
| 32 | Baby throwing bottle | Etiology / Mx / Complications | Failure to thrive in infancy reflects feeding difficulty, hypotonia, reflux, and sometimes hypercalcaemia-related anorexia or vomiting. | The baby rejecting the bottle cues feeding refusal and poor growth. |
| 33 | Hypotonic kid | Etiology / Dx / Mx | Hypotonia in infancy contributes to motor delay, feeding difficulty, and delayed walking. | The floppy child cues low tone as a developmental and feeding contributor. |
| 34 | Figure covering ears | Etiology / Dx / Mx / Complications | Hyperacusis and hearing impairment are common; hyperacusis can drive noise phobia and distress. | Covered ears cue sound sensitivity and audiology follow-up. |
| No. | Symbol | Source tab | Note concept | Etymology / symbol logic |
|---|---|---|---|---|
| 35 | Tray of cocktails | Etiology / Mx / Complications | Williams syndrome has an overfriendly "cocktail party" personality with social vulnerability. | Cocktails cue fluent, indiscriminate social approach. |
| 36 | Elf mask | Etiology / Dx / Summary | Characteristic elfin facies include broad forehead, periorbital fullness, flat nasal bridge, long philtrum, full lips, wide mouth, small widely spaced teeth, prominent ears, and small chin. | The elf mask packages the Williams facial gestalt. |
| 37 | Elf mask with periorbital fullness | Etiology / Dx | Periorbital fullness is a classic Williams facial feature. | Puffy tissue around the elf eyes cues periorbital fullness. |
| 38 | Elf mask with nose cue | Etiology / Dx | This page describes flat nasal bridge with anteverted nares as part of the Williams facial pattern. | The nose on the elf mask cues the Williams nasal configuration, using the page's wording as the source of truth. |
| 39 | Elf mask with wide mouth | Etiology / Dx / Summary | Full or thick lips and a wide mouth are part of the characteristic elfin facies. | The wide mouth makes the "W" in the WILLIAMS mnemonic visible. |
| 40 | Starry glasses | Etiology / Dx / Summary | Stellate iris pattern is a distinctive Williams sign, seen in about half of patients. | Stars over the eyes cue the star-like iris pattern. |
| 41 | Long face | Etiology | Williams facial features become more recognisable with age and may coarsen over time. | The changing face cue reminds you that the gestalt evolves as the child grows. |
| No. | Symbol | Source tab | Note concept | Etymology / symbol logic |
|---|---|---|---|---|
| 42 | Microarray tea chest | Dx / Summary | Williams syndrome is confirmed by FISH, chromosomal microarray, or MLPA showing the 7q11.23 deletion; standard karyotype is normal. | "Tea chest" cues chromosomal microarray as the broad CNV test. |
| 43 | Tray of milks | Dx / Mx / Summary | Check serum total and ionised calcium and urine calcium:creatinine ratio because hypercalcaemia and hypercalciuria are common. | Multiple milk bottles cue measuring calcium burden in blood and urine. |
| 44 | Williams syndrome DDx sign | DDx | Differential diagnoses include Down, Noonan, Turner, DiGeorge, Marfan, Fragile X, fetal alcohol spectrum disorder, and isolated familial SVAS. | The DDx sign turns Williams into the index syndrome among dysmorphic cardiac mimics. |
| No. | Symbol | Source tab | Note concept | Etymology / symbol logic |
|---|---|---|---|---|
| 45 | Ultrasound megaphone with heart boat whistle | Dx / Mx / Complications | Echocardiography evaluates supravalvular aortic stenosis, peripheral pulmonary stenosis, LVH, and cardiac risk. | The ultrasound cue scans the hallmark Williams heart lesion. |
| 46 | Four extremity bracelets | Dx / Mx | Four-limb blood pressure measurement screens for hypertension, BP discrepancy, and arterial stenosis physiology. | Bracelets on all limbs cue BP checks in all four extremities. |
| 47 | High-pressure steam | Etiology / Dx / Mx / Complications | Williams syndrome carries high risk of systemic hypertension, often from renal artery stenosis or generalised elastin arteriopathy. | Steam pressure cues vascular pressure from narrowed arteries. |
| 48 | Small kidney pulley | Dx / Mx / Complications | Renal ultrasound with Doppler screens for CAKUT, nephrocalcinosis, and renal artery stenosis. | The pulled kidney cues structural and renovascular screening. |
| 49 | Telescope | Dx / Mx | Ophthalmology evaluates stellate iris, strabismus, refractive errors, and hypertensive retinopathy risk. | The telescope cue points to formal eye assessment. |
| 50 | Undone thyroid bowtie | Dx / Mx / Complications | Check TSH and free T4 because hypothyroidism is common and can worsen growth and developmental problems if missed. | The loose thyroid bowtie cues thyroid-function testing. |
| No. | Symbol | Source tab | Note concept | Etymology / symbol logic |
|---|---|---|---|---|
| 51 | Gnome-like sailor | Etiology / Mx / Summary | Short stature is typical; growth should be plotted on Williams syndrome-specific growth charts. | The small figure cues short stature and syndrome-specific growth expectations. |
| 52 | "Expect Delays" buoy | Etiology / Dx / Mx / Complications | Developmental delay and intellectual disability are common, with relatively preserved language but marked visuospatial deficits. | The delay sign cues formal developmental and educational assessment. |
| 53 | Rope wrapped around arm and leg | Etiology / Mx / Complications | Joint laxity in childhood can evolve into joint contractures in adolescence or adulthood. | Rope around limbs cues the hypermobility-to-contracture pattern. |
| 54 | "Sleep free or die" sign | Etiology / Mx / Complications | Williams syndrome carries increased sudden cardiac death risk during anaesthesia or sedation, so pre-anaesthetic cardiac review is mandatory. | The sleep/anesthesia warning sign cues that sedation is the danger moment. |
Marfan Syndrome
Marfan syndrome is an autosomal dominant connective tissue disorder caused by mutations in the fibrillin-1 gene, presenting in childhood and adolescence with tall stature, long limbs, arachnodactyly, lens subluxation, and potentially life-threatening aortic root dilation.
DiGeorge Syndrome
DiGeorge syndrome is a congenital condition caused by 22q11.2 microdeletion, presenting in infancy and childhood with thymic hypoplasia (T-cell immunodeficiency), hypoparathyroidism (hypocalcemia), conotruncal cardiac defects, and characteristic facial features.